{"id": "batch_req_67eb6ba57eac819080ddce41837cbdc4", "custom_id": "syn24875850", "response": {"status_code": 200, "request_id": "4facbd78227a3d5b9c4eb175a22b9044", "body": {"id": "chatcmpl-BHNVkFTy1SILiNq5HTncbJarsPX41", "object": "chat.completion", "created": 1743481652, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\",\n    \"creator\": [\n      \"Dr. Gelareh Zadeh\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"DNA methylation\",\n      \"Peripheral leukocytes\",\n      \"Schwannomatosis\",\n      \"Sporadic schwannoma\",\n      \"Immune cell profiling\",\n      \"Non-invasive cancer biomarkers\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn24875850\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"Methylation Study in Schwannomatosis and Sporadic Schwannoma\",\n    \"contributor\": [\n      \"Sheila Mansouri\",\n      \"Robert Allaway\"\n    ],\n    \"countryOfOrigin\": [\n      \"Canada\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"This dataset includes DNA methylation signatures from whole genomic DNA of peripheral blood leukocytes in schwannomatosis and sporadic schwannoma patients for clustering analysis based on immune cell proportions.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 54,\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 54\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5004, "completion_tokens": 354, "total_tokens": 5358, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5908881909414426de6c17a51", "custom_id": "syn21355225", "response": {"status_code": 200, "request_id": "c2d0f947609e4d8ad1d5431937ef22dc", "body": {"id": "chatcmpl-BHNVoQCeDBWrcXZaJoybo35cgpGzK", "object": "chat.completion", "created": 1743481656, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Patient Data\",\n    \"creator\": [\n      \"Elisabeth Castellanos\",\n      \"James Moon\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2-related schwannomatosis\",\n      \"Antisense Oligonucleotides\",\n      \"Exon Skipping\",\n      \"Drug Screening\",\n      \"Polymerase Chain Reaction\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21355225\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"polymerase chain reaction\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 15,\n    \"datePublished\": 2022,\n    \"description\": \"This dataset contains patient data relevant to NF2-related schwannomatosis, including results from drug screening assays. The dataset was generated using polymerase chain reaction and is funded by the Children's Tumour Foundation (CTF).\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5947, "completion_tokens": 279, "total_tokens": 6226, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5a5208190af755fe7a8fbb266", "custom_id": "syn4984604", "response": {"status_code": 200, "request_id": "e381b0910a02b9f3200ce60973298e65", "body": {"id": "chatcmpl-BHNVq1IscNtb6pG7DpOke78fUyvE0", "object": "chat.completion", "created": 1743481658, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Immunohistochemistry\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"Neurofibromatosis\",\n      \"Cutaneous Neurofibromas\",\n      \"Immunohistochemistry\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Immunohistochemistry analysis of cutaneous neurofibromas associated with Neurofibromatosis type 1.\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI to process 2023-07-21\",\n    \"creator\": [\n      \"Thomas Yu\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"Neurofibromatosis\",\n      \"Data Processing\",\n      \"NFOSI\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [],\n    \"funder\": [],\n    \"description\": \"Dataset prepared for NFOSI processing pipeline.\",\n    \"contributor\": [\n      \"Thomas Yu\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Proteomics\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"Proteomics\",\n      \"Cutaneous Neurofibromas\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Proteomic analysis of cutaneous neurofibromas using MudPIT.\",\n    \"measurementTechnique\": [\n      \"MudPIT\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 40,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"RNA-Seq\",\n    \"creator\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Cutaneous Neurofibromas\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"RNA-Seq analysis of cutaneous neurofibromas to characterize gene expression profiles.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 44,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\",\n      \"Robert Allaway\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Raw cNF RNAseq Files\",\n    \"creator\": [],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"Cutaneous Neurofibromas\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw FASTQ files from RNA-Seq analysis of cutaneous neurofibromas.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Raw cNF RNAseq Files (unmerged)\",\n    \"creator\": [],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"Cutaneous Neurofibromas\",\n      \"Unmerged Files\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Unmerged raw FASTQ files from RNA-Seq analysis of cutaneous neurofibromas.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SNP\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"SNP Array\",\n      \"Genomic Variants\",\n      \"Cutaneous Neurofibromas\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"SNP array analysis for identifying genomic variants in cutaneous neurofibromas.\",\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 48,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Sample Information\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"Sample Information\",\n      \"Genomic Variants\",\n      \"Proteomics\",\n      \"Clinical Data\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"proteomics\",\n      \"geneExpression\",\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Comprehensive sample information on cutaneous neurofibromas for various assays.\",\n    \"measurementTechnique\": [\n      \"whole genome sequencing\",\n      \"RNA-seq\",\n      \"MudPIT\",\n      \"SNP array\",\n      \"questionnaire\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"WGS\",\n    \"creator\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"Whole Genome Sequencing\",\n      \"Genomic Variants\",\n      \"Cutaneous Neurofibromas\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Whole Genome Sequencing data for cutaneous neurofibromas associated with Neurofibromatosis type 1.\",\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 15,\n    \"specimenCount\": 62,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"cNF RNA-seq quantification files (salmon)\",\n    \"creator\": [],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Quantification\",\n      \"Salmon\",\n      \"Cutaneous Neurofibromas\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"RNA-Seq quantification files from cutaneous neurofibromas processed with Salmon.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6207, "completion_tokens": 2248, "total_tokens": 8455, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5b8f08190a6eaf75fcc32779b", "custom_id": "syn6633069", "response": {"status_code": 200, "request_id": "2f17e829a45f592ea339646c28adbfce", "body": {"id": "chatcmpl-BHNW2ZFdn4uzblz4kkAcZ3nCquFWR", "object": "chat.completion", "created": 1743481670, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Copy Number Variation from the Columbia University NF1 Glioma Project\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Copy Number Variation\", \"Glioma\", \"Homo sapiens\", \"Whole Exome Sequencing\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn51915976\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"description\": \"Dataset contains copy number variation data from NF1 Glioma cases analyzed using whole exome sequencing.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"CopyNumberVariation\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Copy Number Variation\", \"Glioma\", \"Homo sapiens\", \"Whole Exome Sequencing\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn64954697\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"description\": \"Contains copy number variation data obtained from NF1 Glioma samples using whole exome sequencing.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"GeneExpression\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Gene Expression\", \"Glioma\", \"Homo sapiens\", \"RNA-seq\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn64954698\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 29,\n    \"specimenCount\": 32,\n    \"description\": \"Gene expression dataset derived from NF1 Glioma cases analyzed using RNA sequencing.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Methylation\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Methylation Array\", \"Chromatin Activity\", \"Glioma\", \"Homo sapiens\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn64954699\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"methylation array\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 31,\n    \"specimenCount\": 31,\n    \"description\": \"Methylation data from NF1 Glioma samples using methylation arrays to study chromatin activity.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NucleotideVariation\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Nucleotide Variation\", \"Glioma\", \"Homo sapiens\", \"Whole Exome Sequencing\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn64954700\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 56,\n    \"specimenCount\": 102,\n    \"description\": \"Whole exome sequencing data detailing nucleotide variants found in NF1 Glioma samples.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"WholeGenomeVariants\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Genome Variants\", \"Glioma\", \"Homo sapiens\", \"Whole Genome Sequencing\", \"Genomic Variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn64954701\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 11,\n    \"specimenCount\": 22,\n    \"description\": \"Variant data from whole genome sequencing of NF1 Glioma samples.\",\n    \"manifestation\": [\"Low-Grade Glioma\", \"High-Grade Glioma\"],\n    \"contributor\": [\"Fulvio D'Angelo\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5284, "completion_tokens": 1381, "total_tokens": 6665, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5cc8c8190b00416aa20845002", "custom_id": "syn26347297", "response": {"status_code": 200, "request_id": "b9215e84c36814c0d0de5353d9095465", "body": {"id": "chatcmpl-BHNWAQPkvIQt5IRlbbplzMDJcUSLv", "object": "chat.completion", "created": 1743481678, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Flow Cytometry\",\n    \"creator\": [\n      \"Lindy Zhang\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RAS signaling pathway\",\n      \"MEK inhibitors\",\n      \"SHP2 inhibitors\",\n      \"CDK inhibitors\",\n      \"tumor microenvironment\",\n      \"immunotherapy\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn26347297\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset explores the effects of RAS signaling pathway inhibitors on malignant peripheral nerve sheath tumors using flow cytometry.\",\n    \"contributor\": [\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\"\n    ],\n    \"institution\": [\n      \"Johns Hopkins University\"\n    ],\n    \"measurementTechnique\": [\n      \"flow cytometry\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"species\": [\n      \"Homo sapiens\"\n    ]\n  },\n  {\n    \"title\": \"Immunohistochemistry\",\n    \"creator\": [\n      \"Lindy Zhang\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RAS signaling pathway\",\n      \"MEK inhibitors\",\n      \"SHP2 inhibitors\",\n      \"CDK inhibitors\",\n      \"tumor microenvironment\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn26347297\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset examines the role of the tumor microenvironment and the impact of various inhibitors on immune cells using immunohistochemistry.\",\n    \"contributor\": [\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\"\n    ],\n    \"institution\": [\n      \"Johns Hopkins University\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"species\": [\n      \"Homo sapiens\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4528, "completion_tokens": 542, "total_tokens": 5070, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5e0948190800d63d073437cb9", "custom_id": "syn11817821", "response": {"status_code": 200, "request_id": "73de3bf809289acf19880502244a3f2a", "body": {"id": "chatcmpl-BHNWDf3y3yToXAkOKkQqlvXLT3QwC", "object": "chat.completion", "created": 1743481681, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Exp008_analyzed Data\",\n    \"creator\": [\"Jeffrey Field\", \"yang yang\"],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability assay\", \"immunofluorescence\", \"MPNST\", \"analysis\"],\n    \"dataType\": [\"drugScreen\", \"image\"],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Analyzed data including cell viability assays and immunofluorescence, focusing on MPNST cell lines' response to cancer drugs.\",\n    \"measurementTechnique\": [\"cell viability assay\", \"immunofluorescence\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Raw Data and logs\",\n    \"creator\": [\"Jeffrey Field\", \"yang yang\"],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"drug screen\", \"raw data\", \"neurofibromatosis\", \"MPNST\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\", \"NF2-related schwannomatosis\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Raw datasets and logs from drug screening studies on different neurofibromatosis-related tumors.\",\n    \"measurementTechnique\": [\"cell viability assay\", \"drug screen\"],\n    \"species\": [\"Homo sapiens\", \"Rattus norvegicus\"],\n    \"specimenCount\": 27,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"exome sequencing\",\n    \"creator\": [\"Jeffrey Field\", \"Robert Allaway\"],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"whole exome sequencing\", \"genomic variants\", \"neurofibromatosis\", \"cancer\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\", \"NF2-related schwannomatosis\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Exome sequencing data highlighting genomic variants from patients with neurofibromatosis and associated tumors.\",\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5384, "completion_tokens": 598, "total_tokens": 5982, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba5f2488190b0193142b2a322a3", "custom_id": "syn4939876", "response": {"status_code": 200, "request_id": "e6e7c0fbc75554d89acc11e6e0ff6e33", "body": {"id": "chatcmpl-BHNWHY7U80fdH6qG8BaEbb2aeJZRG", "object": "chat.completion", "created": 1743481685, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Spreadsheets\",\n    \"creator\": [\n      \"D. Wade Clapp, M.D.\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drugScreen\",\n      \"cell viability assay\",\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"In vitro\",\n      \"Primary murine embryonic Schwann cells\",\n      \"MTC line\",\n      \"HTS validation\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn4939876\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"This dataset includes in vitro drug screen data aimed at validating high-throughput screening results with a focus on Neurofibromatosis type 1 and Plexiform Neurofibroma. The data involves assays conducted on murine and human-derived cell lines.\",\n    \"contributor\": [\n      \"Heather Daniel\",\n      \"Xindi Guo\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"datePublished\": 20151231,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4833, "completion_tokens": 341, "total_tokens": 5174, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6048481908983a9fb0e215a08", "custom_id": "syn22267330", "response": {"status_code": 200, "request_id": "92394f1efe5392dc61c86f75fe90868b", "body": {"id": "chatcmpl-BHNWKdh81OSVEUQ0uUcKcFBIUMcrj", "object": "chat.completion", "created": 1743481688, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Cell Viability Celigo Assays\",\n    \"creator\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"ErbB3\",\n      \"Calcium Signaling\",\n      \"MPNST\",\n      \"Cell Viability\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\",\n      \"drugCombinationScreen\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset contains cell viability assay data focusing on the role of ErbB3 and calcium signaling pathways in MPNST proliferation and survival.\",\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Imaging\",\n    \"creator\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunocytochemistry\",\n      \"MPNST\",\n      \"Imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset contains immunocytochemistry imaging data related to MPNST tumor studies.\",\n    \"measurementTechnique\": [\n      \"immunocytochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Kinomics\",\n    \"creator\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Kinomics\",\n      \"Immunoassay\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Kinomics dataset exploring the regulatory pathways in MPNST using immunoassay data.\",\n    \"measurementTechnique\": [\n      \"immunoassay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Microarray\",\n    \"creator\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Microarray\",\n      \"Gene Expression\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Microarray data providing gene expression insights in MPNST studies.\",\n    \"measurementTechnique\": [\n      \"array\"\n    ],\n    \"species\": [\n      \"Rattus norvegicus\"\n    ],\n    \"individualCount\": 1,\n    \"specimenCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5597, "completion_tokens": 872, "total_tokens": 6469, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba619208190a4afd23b8f410f6f", "custom_id": "syn31619419", "response": {"status_code": 200, "request_id": "a47412a073fe0db884eeac66a2245270", "body": {"id": "chatcmpl-BHNWPOsk4JxsqZC3QwQHZYW9Qz0xJ", "object": "chat.completion", "created": 1743481693, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Analysis\",\n    \"creator\": [\n      \"Wangcun Jia\",\n      \"Junsoo Lee\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"optical coherence tomography\",\n      \"spatial frequency domain imaging\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"NF1\",\n      \"image data\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"measurementTechnique\": [\n      \"spatial frequency domain imaging\",\n      \"optical coherence tomography\"\n    ],\n    \"description\": \"This dataset includes analysis data from optical coherence tomography and spatial frequency domain imaging studies aimed at improving the quality of life of NF1 patients by detecting and assessing cutaneous neurofibromas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Histology\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"brightfield microscopy\",\n      \"histology\",\n      \"cutaneous neurofibroma\",\n      \"image data\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"description\": \"The dataset contains histological images using brightfield microscopy to support the research on cutaneous neurofibromas and validate optical biomarkers for NF1.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"OCT data\",\n    \"creator\": [\n      \"Junsoo Lee\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"optical coherence tomography\",\n      \"OCT\",\n      \"image data\",\n      \"cutaneous neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"measurementTechnique\": [\n      \"optical coherence tomography\"\n    ],\n    \"description\": \"OCT data aimed at improving detection and assessment of cutaneous neurofibromas as part of NF1 treatment strategies.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Photos\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"photograph\",\n      \"image data\",\n      \"cutaneous neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"measurementTechnique\": [\n      \"photograph\"\n    ],\n    \"description\": \"Photographic dataset capturing images related to cutaneous neurofibromas for visual documentation and analysis in NF1 research.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SFDI data\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"spatial frequency domain imaging\",\n      \"SFDI\",\n      \"image data\",\n      \"cutaneous neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"measurementTechnique\": [\n      \"spatial frequency domain imaging\"\n    ],\n    \"description\": \"This dataset includes images and metadata from spatial frequency domain imaging used to detect and evaluate cutaneous neurofibromas in NF1 patients.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5299, "completion_tokens": 1092, "total_tokens": 6391, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba62d1081909cd1c3c4c7919a2d", "custom_id": "syn4939890", "response": {"status_code": 200, "request_id": "becba03bdeb5ddd6eb7d53aa94e40fbd", "body": {"id": "chatcmpl-BHNVkBsVG1bfKWNwyHnk4Uq09aJXl", "object": "chat.completion", "created": 1743481652, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Gene expression profiling of Schwann cells and macrophages in mouse nerves and neurofibromas\",\n    \"creator\": [\n      \"Kwangmn Choi\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwann cells\",\n      \"macrophages\",\n      \"mouse nerves\",\n      \"neurofibromas\",\n      \"gene expression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939890\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"This dataset contains gene expression profiles of Schwann cells and macrophages in mouse nerves and neurofibromas to identify cytokine/chemokine pathways that influence tumor growth.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5292, "completion_tokens": 247, "total_tokens": 5539, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba640648190b49b90324466738b", "custom_id": "syn7217928", "response": {"status_code": 200, "request_id": "5cd9aee168f8c063cd850946e972a700", "body": {"id": "chatcmpl-BHNVmgAeZTVNbkvaZefnW9OokuYQd", "object": "chat.completion", "created": 1743481654, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Drug screen data\",\n    \"creator\": [\"Anh Nguyet Vu\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"drug screen\", \"3D culture\", \"Plexiform Neurofibroma\", \"NF1\", \"preclinical models\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn64954702\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset contains drug screening data for testing potential treatments in 3D culture models of Plexiform Neurofibroma, related to NF1 patients.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\"Ray Mattingly, Ph.D.\"],\n    \"datePublished\": 2013,\n    \"measurementTechnique\": [\"3D microtissue viability\"]\n  },\n  {\n    \"title\": \"Drug screens with 3D Plexiform Neurofibroma Model System\",\n    \"creator\": [\"Anh Nguyet Vu\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"drug screen\", \"3D culture\", \"Plexiform Neurofibroma\", \"NF1\", \"preclinical models\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn52163155\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset includes drug screens using a 3D Plexiform Neurofibroma model system for NF1, aimed at improving preclinical drug screening and translational effectiveness.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\"Ray Mattingly, Ph.D.\"],\n    \"datePublished\": 2013,\n    \"measurementTechnique\": [\"3D microtissue viability\"]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5483, "completion_tokens": 433, "total_tokens": 5916, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba65310819086f0de761f4e1ce5", "custom_id": "syn61696875", "response": {"status_code": 200, "request_id": "26e03dbc2bc27d0383e86a7b8f15ebef", "body": {"id": "chatcmpl-BHNVpHUSJTfJ9w49XsGdiIqc4yuzA", "object": "chat.completion", "created": 1743481657, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Mayo Clinic cohort REDCap database of de-identified phenotype and genotype information\",\n    \"creator\": [\n      \"Mayowa Osundiji\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis\",\n      \"REDCap\",\n      \"phenotype\",\n      \"genotype\",\n      \"clinical data\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn61696875\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset contains de-identified phenotype and genotype information extracted from electronic health records from Mayo Clinic Rochester. It is part of a project to enhance the Children's Tumor Foundation Neurofibromatosis registry.\",\n    \"contributor\": [\n      \"Mayowa Osundiji\",\n      \"Marlene Girardo\"\n    ],\n    \"countryOfOrigin\": [\n      \"United States\"\n    ],\n    \"individualCount\": 1,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": [\n      \"genotyping\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"datePublished\": 2024\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4802, "completion_tokens": 347, "total_tokens": 5149, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6661c8190831c2875bcda2ebc", "custom_id": "syn2343195", "response": {"status_code": 200, "request_id": "6ea983bec690b5baaafc162126e3e920", "body": {"id": "chatcmpl-BHNVsIHnxeTrHVs5recNdYXi3Qivx", "object": "chat.completion", "created": 1743481660, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"2017 Release - Jumping Library Seq\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"jumping library\", \"genomicVariants\", \"NF2\", \"Meningioma\", \"Schwannoma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"The dataset contains genomic variant data for detecting chromosomal abnormalities using jumping library sequencing from 11 human and mouse cell line models with NF2 wildtype or deficient status.\",\n    \"contributor\": [\"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 11,\n    \"specimenCount\": 12,\n    \"manifestation\": [\"Meningioma\", \"Schwannoma\"],\n    \"measurementTechnique\": [\"Jumping library\"]\n  },\n  {\n    \"title\": \"2017 Release - Proteomics_Kinome\",\n    \"creator\": [\"Abhishek Pratap\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"kinomics\", \"MIB/MS\", \"NF2\", \"Meningioma\", \"Schwannoma\"],\n    \"dataType\": [\"kinomics\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Proteomics data containing kinome profiling after treatment with various small molecules, analyzed using MIB/MS in human and mouse models.\",\n    \"contributor\": [\"Abhishek Pratap\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 11,\n    \"specimenCount\": 9,\n    \"manifestation\": [\"Meningioma\", \"Schwannoma\"],\n    \"measurementTechnique\": [\"MIB/MS\"]\n  },\n  {\n    \"title\": \"2019 Release - Animal Studies\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"in vivo bioluminescence\", \"volume\", \"NF2\", \"Meningioma\"],\n    \"dataType\": [\"Volume\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"The dataset includes in vivo bioluminescence data of animal studies investigating tumor volumes in mouse models with meningioma.\",\n    \"contributor\": [\"Robert Allaway\"],\n    \"species\": [\"Mus musculus\", \"Homo sapiens\"],\n    \"specimenCount\": 2,\n    \"manifestation\": [\"Meningioma\"],\n    \"measurementTechnique\": [\"In vivo bioluminescence\"]\n  },\n  {\n    \"title\": \"2019 Release - High-Throughput Drug Screens\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability assay\", \"drugScreen\", \"NF2\", \"Meningioma\", \"Schwannoma\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"High-throughput drug screening data using cell viability assays on models of meningioma and schwannoma.\",\n    \"contributor\": [\"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 7,\n    \"specimenCount\": 15,\n    \"manifestation\": [\"Meningioma\", \"Schwannoma\"],\n    \"measurementTechnique\": [\"Cell viability assay\"]\n  },\n  {\n    \"title\": \"2019 Release - Proteomics_Kinome\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"kinomics\", \"immunoassay\", \"MIB/MS\", \"sandwich ELISA\", \"NF2\", \"Meningioma\", \"Schwannoma\"],\n    \"dataType\": [\"kinomics\", \"immunoassay\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Proteomics and immunoassay data for kinomics assessment using MIB/MS and sandwich ELISA techniques on human and mouse models.\",\n    \"contributor\": [\"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 3,\n    \"specimenCount\": 2,\n    \"manifestation\": [\"Meningioma\", \"Schwannoma\"],\n    \"measurementTechnique\": [\"MIB/MS\", \"Sandwich ELISA\"]\n  },\n  {\n    \"title\": \"2019 Release - RNASeq\",\n    \"creator\": [\"Serkan Erdin\", \"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"NF2\", \"Meningioma\", \"Schwannoma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"RNA-seq data for gene expression profiling in human and mouse models with treatments across multiple experiment settings.\",\n    \"contributor\": [\"Serkan Erdin\", \"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 8,\n    \"specimenCount\": 109,\n    \"manifestation\": [\"Meningioma\", \"Schwannoma\"],\n    \"measurementTechnique\": [\"RNA-seq\"]\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"NF2\", \"Schwannoma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Gene expression quantification data derived from RNA-seq analysis of schwannoma models.\",\n    \"contributor\": [\"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 2,\n    \"manifestation\": [\"Schwannoma\"],\n    \"measurementTechnique\": [\"RNA-seq\"]\n  },\n  {\n    \"title\": \"NF-OSI RNASeq Reprocessing\",\n    \"creator\": [\"Sara Gosline\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"NF2\", \"Meningioma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Processed RNA-seq data reanalysis providing expression profiles and insights into NF2-related meningioma.\",\n    \"contributor\": [\"Sara Gosline\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 75,\n    \"specimenCount\": 84,\n    \"manifestation\": [\"Meningioma\"],\n    \"measurementTechnique\": [\"RNA-seq\"]\n  },\n  {\n    \"title\": \"Synodos NF2 RNA-seq Raw Data - 2017 Release\",\n    \"creator\": [\"Steven Angus\", \"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"NF2\", \"Schwannoma\", \"Meningioma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 2\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Raw RNA-seq data capturing gene expression profiles across various tumor type models specific to NF2.\",\n    \"contributor\": [\"Steven Angus\", \"Robert Allaway\"],\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"individualCount\": 47,\n    \"specimenCount\": 205,\n    \"manifestation\": [\"Schwannoma\", \"Meningioma\"],\n    \"measurementTechnique\": [\"RNA-seq\"]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7130, "completion_tokens": 1928, "total_tokens": 9058, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba67ae08190ac616a52ee6cd4cc", "custom_id": "syn11374349", "response": {"status_code": 200, "request_id": "02ab0cb93b608d44560ec5093463192e", "body": {"id": "chatcmpl-BHNVmRkc7vrtUEDThDseX9UW68Uj3", "object": "chat.completion", "created": 1743481654, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"immunohistochemistry\", \"quantitative PCR\", \"flow cytometry\"],\n    \"dataType\": [\"image\", \"geneExpression\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 1,\n    \"measurementTechnique\": [\"immunohistochemistry\", \"quantitative PCR\", \"flow cytometry\"],\n    \"description\": \"Dataset includes immunohistochemistry, quantitative PCR, and flow cytometry data essential for NF1 Schwann cell research.\"\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"western blot\", \"flow cytometry\", \"quantitative PCR\", \"immunohistochemistry\", \"immunofluorescence\"],\n    \"dataType\": [\"image\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"western blot\", \"flow cytometry\", \"quantitative PCR\", \"immunohistochemistry\", \"immunofluorescence\"],\n    \"description\": \"This dataset comprises western blot, flow cytometry, quantitative PCR, immunohistochemistry, and immunofluorescence data for NF1 research.\"\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"western blot\", \"quantitative PCR\", \"immunofluorescence\", \"immunocytochemistry\"],\n    \"dataType\": [\"geneExpression\", \"immunoassay\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"measurementTechnique\": [\"western blot\", \"quantitative PCR\", \"immunofluorescence\", \"immunocytochemistry\"],\n    \"description\": \"Dataset consisting of western blot, quantitative PCR, immunofluorescence, and immunocytochemistry for furthering NF1 Schwann cell studies.\"\n  },\n  {\n    \"title\": \"30 month deliverables\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"immunocytochemistry\", \"atomic force microscopy\", \"immunofluorescence\", \"RNA-seq\", \"quantitative PCR\"],\n    \"dataType\": [\"immunoassay\", \"image\", \"geneExpression\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"measurementTechnique\": [\"immunocytochemistry\", \"atomic force microscopy\", \"immunofluorescence\", \"RNA-seq\", \"quantitative PCR\"],\n    \"description\": \"Contains data from immunocytochemistry, atomic force microscopy, immunofluorescence, RNA-seq, and quantitative PCR for NF1 research.\"\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": [\"Gabsang Lee\", \"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"cell viability assay\", \"quantitative PCR\", \"atomic force microscopy\", \"RNA-seq\", \"immunofluorescence\"],\n    \"dataType\": [\"cellularPhysiology\", \"geneExpression\", \"image\", \"immunoassay\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 16,\n    \"measurementTechnique\": [\"cell viability assay\", \"quantitative PCR\", \"atomic force microscopy\", \"RNA-seq\", \"immunofluorescence\"],\n    \"description\": \"This dataset provides insights using cell viability assays, quantitative PCR, atomic force microscopy, RNA-seq, and immunofluorescence for NF1.\"\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"Sanger sequencing\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"Sanger sequencing\"],\n    \"description\": \"Includes Sanger sequencing data crucial for the analysis of genomic variants in Schwann cells for NF1 research.\"\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"RNA-seq\", \"gene expression\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NF Service\"],\n    \"species\": [\"Homo sapiens\"],\n    \"specimenCount\": 16,\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"description\": \"Dataset centered on RNA-seq for gene expression quantification in NF1 Schwann cell research.\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\"Gabsang Lee\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NF1\", \"Schwann cells\", \"RNA-seq\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"contributor\": [\"NTAP\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"description\": \"This dataset includes RNA-seq data important for gene expression studies in NF1 Schwann cell research.\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5995, "completion_tokens": 1578, "total_tokens": 7573, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba68e508190aee31e758adaabb5", "custom_id": "syn5698493", "response": {"status_code": 200, "request_id": "878355f4f7a9604e907c0015387a2c85", "body": {"id": "chatcmpl-BHNW2P9QrXxBpjGgoDYCm3WSOekLI", "object": "chat.completion", "created": 1743481670, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Synodos LGG Methylation Arrays\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"methylation array\", \"chromatinActivity\", \"Neurofibromatosis type 1\", \"CTF\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset contains methylation array data for low-grade glioma associated with Neurofibromatosis type 1, with a focus on chromatin activity.\",\n    \"contributor\": [\"CTF Synodos for NF1\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 43,\n    \"specimenCount\": 43,\n    \"measurementTechnique\": [\"methylation array\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Synodos LGG RNAseq\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"3D microtissue viability\", \"geneExpression\", \"Neurofibromatosis type 1\", \"CTF\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset includes RNA sequencing data related to low-grade glioma in Neurofibromatosis type 1, specifically focusing on gene expression.\",\n    \"contributor\": [\"CTF Synodos for NF1\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 23,\n    \"specimenCount\": 23,\n    \"measurementTechnique\": [\"RNA-seq\", \"3D microtissue viability\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Synodos LGG Whole Genome Sequencing (bam)\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"whole genome sequencing\", \"Neurofibromatosis type 1\", \"genomicVariants\", \"CTF\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"Whole genome sequencing dataset in BAM format for low-grade glioma cases in Neurofibromatosis type 1.\",\n    \"contributor\": [\"CTF Synodos for NF1\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 22,\n    \"specimenCount\": 44,\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5223, "completion_tokens": 675, "total_tokens": 5898, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6a3b881909b09bf39695eaeb3", "custom_id": "syn21984813", "response": {"status_code": 200, "request_id": "2e6a5122efc34e632864ab8f016fd363", "body": {"id": "chatcmpl-BHNVvV5JO9wZWIUdDDzDgSJ2vZMDo", "object": "chat.completion", "created": 1743481663, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"Animal Tumor Growth Studies\",\n        \"creator\": [\n            \"Ana Calizo\",\n            \"himanshi bhatia\",\n            \"Daniel Schefer\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"in vivo tumor growth\",\n            \"Neurofibromatosis type 1\",\n            \"Malignant Peripheral Nerve Sheath Tumor\",\n            \"drugScreen\"\n        ],\n        \"dataType\": [\n            \"drugScreen\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"in vivo tumor growth\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 9,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"A dataset focused on in vivo tumor growth studies using human specimens, analyzing Neurofibromatosis type 1 and Malignant Peripheral Nerve Sheath Tumor, featuring drug screening techniques.\"\n    },\n    {\n        \"title\": \"Batch 1 RNA-seq (Drug Treated Cell Lines)\",\n        \"creator\": [\n            \"Unknown\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RNA-seq\",\n            \"Drug Treated Cell Lines\",\n            \"Gene Expression\"\n        ],\n        \"dataType\": [\n            \"geneExpression\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"This dataset includes RNA-seq data from drug-treated cell lines, part of research on Neurofibromatosis type 1.\"\n    },\n    {\n        \"title\": \"Cell_growth_data_annotation_files\",\n        \"creator\": [\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Cell Growth\",\n            \"Data Annotation\"\n        ],\n        \"dataType\": [\n            \"geneExpression\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Annotation files related to cell growth data, supporting research on Neurofibromatosis type 1.\"\n    },\n    {\n        \"title\": \"Drug Combo Incucyte\",\n        \"creator\": [\n            \"Sara Gosline\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Drug Combination\",\n            \"Incucyte\"\n        ],\n        \"dataType\": [\n            \"drugScreen\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Dataset consisting of drug combination experiments using the Incucyte system, for Neurofibromatosis type 1 research.\"\n    },\n    {\n        \"title\": \"Hirbe_s5180_MGI0731_Batch2_RNAseq\",\n        \"creator\": [\n            \"Kuangying Yang\",\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RNA-seq\",\n            \"Batch 2\",\n            \"Gene Expression\"\n        ],\n        \"dataType\": [\n            \"geneExpression\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 8,\n        \"specimenCount\": 16,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"RNA-seq data for Batch 2 focusing on gene expression analysis related to Neurofibromatosis type 1.\"\n    },\n    {\n        \"title\": \"Incucyte Drug Response Data\",\n        \"creator\": [\n            \"Ana Calizo\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Incucyte\",\n            \"Drug Response\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"drugScreen\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"cell viability assay\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 4,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Data on the response of human cells to drugs using Incucyte assays, as part of Neurofibromatosis type 1 research.\"\n    },\n    {\n        \"title\": \"JH_Samples_WEX_MAF\",\n        \"creator\": [\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"WEX\",\n            \"MAF\",\n            \"Genomic Variants\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"whole exome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 6,\n        \"specimenCount\": 6,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Whole exome sequencing data listing genomic variants in samples related to Neurofibromatosis type 1.\"\n    },\n    {\n        \"title\": \"MGI_DT-2862929_Batch2_WEX\",\n        \"creator\": [\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"WEX\",\n            \"Batch 2\",\n            \"Genomic Variants\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Multiple\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"whole exome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 8,\n        \"specimenCount\": 21,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Whole exome sequencing of batch 2 samples providing insights into genomic variants in the context of Neurofibromatosis type 1.\"\n    },\n    {\n        \"title\": \"MGI_DT-2862929_Batch2_WEX_BAM\",\n        \"creator\": [\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"WEX\",\n            \"Batch 2\",\n            \"BAM files\",\n            \"Genomic Variants\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Multiple\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"whole exome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 8,\n        \"specimenCount\": 14,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"A dataset comprised of BAM files from whole exome sequencing, advancing the understanding of genomic variants in various conditions.\"\n    },\n    {\n        \"title\": \"MGI_DT-2862930_Batch2_WGS\",\n        \"creator\": [\n            \"Yang Lyu\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"WGS\",\n            \"Batch 2\",\n            \"Genomic Variants\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn21984813\",\n        \"diseaseFocus\": [\n            \"Multiple\"\n        ],\n        \"funder\": [\n            \"NTAP\",\n            \"NIH-NCI\"\n        ],\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 8,\n        \"specimenCount\": 22,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"description\": \"Whole genome sequencing for batch 2 offering comprehensive genomic variant information across various Neurofibromatosis type 1 conditions.\"\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 8954, "completion_tokens": 2191, "total_tokens": 11145, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6b6748190b296fd9afd74685b", "custom_id": "syn5562324", "response": {"status_code": 200, "request_id": "6c0cefc2f8018ced1963db7102a43f68", "body": {"id": "chatcmpl-BHNW6mQMRa7vDUbF8IHqsLk3enkOM", "object": "chat.completion", "created": 1743481674, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"CTF-UCF-Cenix Complete Compound Drug Screen\",\n    \"creator\": [\n      \"Abhishek Pratap\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Drug Screen\",\n      \"High Content Assays\",\n      \"NF2\",\n      \"Schwann Cells\",\n      \"Phenotypic Measurements\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"image\"\n    ],\n    \"studyId\": \"syn5562324\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Children's Tumor Foundation\",\n      \"Dr. Cristina Fernandez-Valle\",\n      \"Cenix Bioscience\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"description\": \"Phenotypic screening of anti-NF2 drug candidates using image-based assays in merlin-deficient and normal mouse schwann cells. The data includes measurements of different nuclear phenotypes after drug treatments.\",\n    \"measurementTechnique\": [\n      \"high content screen\",\n      \"cell proliferation\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4601, "completion_tokens": 284, "total_tokens": 4885, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6cb0881908ede18acb6e173a7", "custom_id": "syn22392179", "response": {"status_code": 200, "request_id": "8ad4a3bf1a32408f48db0a72aa03efa8", "body": {"id": "chatcmpl-BHNW7BcfuMSLRqNHQamWMPDYtpEmJ", "object": "chat.completion", "created": 1743481675, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"MPNST Cell Line Methylation Arrays\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Methylation\",\n      \"Cell Lines\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset provides methylation array data for 8 MPNST cell lines, including chromatin activity data. The study includes potential misdiagnosis identified by a methylation-based sarcoma classifier.\"\n  },\n  {\n    \"title\": \"MPNST Cell Line SNP Arrays\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"SNP Arrays\",\n      \"Cell Lines\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset provides SNP array data for 8 MPNST cell lines, which is essential for the study of genomic variants within these samples.\"\n  },\n  {\n    \"title\": \"MPNST Cell Line Whole Exome Sequencing\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Whole Exome Sequencing\",\n      \"Cell Lines\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset includes whole exome sequencing data for 8 MPNST cell lines, providing insights into genomic variants that may influence MPNST pathogenesis.\"\n  },\n  {\n    \"title\": \"MPNST Cell Line Whole Genome Sequencing\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Whole Genome Sequencing\",\n      \"Cell Lines\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset consists of whole genome sequencing data for 8 MPNST cell lines, crucial for in-depth genomic variant analysis in cancer research.\"\n  },\n  {\n    \"title\": \"Methylation\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Methylation\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset contains methylation data for 8 MPNST cell lines, highlighting chromatin activity and providing insights into epigenomic changes.\"\n  },\n  {\n    \"title\": \"SNP_array\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"SNP Arrays\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset includes SNP array data for 8 MPNST cell lines, fundamental for genomic variant studies in cancer research.\"\n  },\n  {\n    \"title\": \"WES\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Whole Exome Sequencing\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset provides whole exome sequencing data for 8 MPNST cell lines, key for researching genomic variants in cancer.\"\n  },\n  {\n    \"title\": \"WGS\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Whole Genome Sequencing\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory\",\n      \"Germans Trias i Pujol Research Institute\"\n    ],\n    \"countryOfOrigin\": [\n      \"Spain\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset comprises whole genome sequencing data for 8 MPNST cell lines, crucial for understanding genomic variants in MPNST research.\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7032, "completion_tokens": 2252, "total_tokens": 9284, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6e2d08190aa15f8242e86f71a", "custom_id": "syn11672851", "response": {"status_code": 200, "request_id": "789ba7481185c99404615a7f1083ccda", "body": {"id": "chatcmpl-BHNW9retsZ0yrVeQdiTKhU0RPqdHt", "object": "chat.completion", "created": 1743481677, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Drug-Target Explorer\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY-SA\",\n    \"keywords\": [\"drug discovery\", \"oncology\", \"drug-target interaction\", \"chemical space\", \"biological targets\", \"ChEMBL\", \"DrugBank\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn11672851\",\n    \"diseaseFocus\": [\"Multiple\"],\n    \"funder\": [\"Other\"],\n    \"description\": \"The Drug-Target Explorer is a tool for exploring chemical-biological interactions in oncology drug discovery. It utilizes data from ChEMBL, ChemicalProbes.org, DGIdb, and DrugBank to promote target discovery and lead identification.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"datePublished\": 2021\n  }\n]\n```\n", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5522, "completion_tokens": 201, "total_tokens": 5723, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba6f8148190b1fd5c3c806b3000", "custom_id": "syn37861830", "response": {"status_code": 200, "request_id": "a80b88367d1856127c6dda45a695361c", "body": {"id": "chatcmpl-BHNWH6LR7EAoqHzOtPUVaMzyTnpHC", "object": "chat.completion", "created": 1743481685, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the curated JSON metadata for the dataset based on the provided information:\n\n```json\n[\n  {\n    \"title\": \"IHC Quantification\",\n    \"creator\": [\n      \"Bandarigoda Nipunika Somatilaka\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"neurofibromatosis type 1\",\n      \"malignant peripheral nerve sheath tumor\",\n      \"immunohistochemistry\",\n      \"raw counts\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn37861830\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"IHC Quantification for NF1 MPNST\",\n    \"contributor\": [\n      \"Anh Nguyet Vu\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"This dataset contains quantification data from immunohistochemistry assays performed on Malignant Peripheral Nerve Sheath Tumor (MPNST) in Mus musculus, aiming to explore treatment strategies for Neurofibromatosis type 1.\",\n    \"visualizeDataOn\": [\n      \"Example visualization platform URL\"\n    ]\n  }\n]\n```\n\n- \"accessType\" is assumed as \"Controlled Access\" due to research involvement and the nature of the dataset.\n- \"alternateName\" provides a descriptive alternative title.\n- \"visualizeDataOn\" is a placeholder for any visualization platforms, omitted if unknown.\n- \"individualCount\" and \"specimenCount\" are omitted as they are unknown.\n- \"measurementTechnique\" accurately reflects the provided assay.\n- \"species\" is included since it's provided in the project data.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5038, "completion_tokens": 446, "total_tokens": 5484, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba70d98819097e0c870b294ff59", "custom_id": "syn4939874", "response": {"status_code": 200, "request_id": "bc94b529a83dbd98184ba1811201f035", "body": {"id": "chatcmpl-BHNWBQ8YCo9QLg6BiTtAmt2AmRs6G", "object": "chat.completion", "created": 1743481679, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"NFOSI-WES-To-Process-2024-03\",\n    \"creator\": [\n      \"Sara Gosline\",\n      \"Xindi Guo\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole Exome Sequencing\",\n      \"Gene Expression\",\n      \"Cell Culture\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Selected pNF cell line Kallisto output\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Kallisto\",\n      \"Gene Expression\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"pNF Cell Line RNA-seq (NFOSIprocessing-2022-04-18)\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Plexiform Neurofibroma\",\n      \"Fastq\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 11,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5254, "completion_tokens": 522, "total_tokens": 5776, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba721dc81909cce9576f0f4442d", "custom_id": "syn8016650", "response": {"status_code": 200, "request_id": "13e92bfe46502795c3d7f24df0692a3c", "body": {"id": "chatcmpl-BHNWLb4ruCdfUZ7Uly9XSqekj7iDJ", "object": "chat.completion", "created": 1743481689, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"ATP hydrolisis rate\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"ATPase activity\", \"TRAP1\", \"hydrolysis\", \"NF1\"],\n    \"dataType\": [\"AggregatedData\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"ATPase activity assay\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"CRC\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Calcium retention\", \"TRAP1\", \"capacity\", \"NF1\"],\n    \"dataType\": [\"AggregatedData\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"calcium retention capacity assay\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"NADH dehydrogenase activity\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"NADH\", \"dehydrogenase\", \"activity\"],\n    \"dataType\": [],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"OCR and ECAR\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"oxygen consumption\", \"ECAR\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"AggregatedData\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"oxygen consumption assay\"],\n    \"species\": [\"Homo sapiens\", \"Danio rerio\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"SDH activity\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"SDH activity\", \"sorbitol\", \"dehydrogenase\", \"TRAP1\", \"NF1\", \"MPNST\"],\n    \"dataType\": [\"csv\", \"excel\", \"jpg\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"sorbitol dehydrogenase activity level assay\"],\n    \"species\": [\"Mus musculus\", \"Homo sapiens\", \"Danio rerio\"],\n    \"manifestation\": [\"Plexiform Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SDS and BN-PAGE\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"SDS-PAGE\", \"blue native PAGE\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"word\", \"excel\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"SDS-PAGE\", \"blue native PAGE\", \"gel filtration chromatography\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"Split GFP\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Split GFP\", \"TRAP1\"],\n    \"dataType\": [\"experimentalData\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"Split GFP\"],\n    \"species\": [\"Mus musculus\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"TRAP1-HSP90 ATPase activity\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"TRAP1\", \"HSP90\", \"ATPase\", \"activity\"],\n    \"dataType\": [\"csv\", \"jpg\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"ATPase activity assay\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"cell proliferation\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell proliferation\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"csv\", \"jpg\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"cell proliferation\"],\n    \"species\": [\"Mus musculus\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"cell viability\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"csv\", \"image\", \"jpg\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"cell viability assay\"],\n    \"species\": [\"Mus musculus\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"compound list\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"compound list\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"fluorescence microscopy\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"fluorescence microscopy\", \"TRAP1\"],\n    \"dataType\": [],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"microscopy\"],\n    \"species\": [\"Mus musculus\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"immunohistochemistry\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"immunohistochemistry\", \"TRAP1\"],\n    \"dataType\": [\"image\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"immunohistochemistry\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"in vitro interaction\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"in vitro interaction\", \"TRAP1\"],\n    \"dataType\": [\"word\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"in vitro tumorigenesis\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"in vitro tumorigenesis\", \"TRAP1\", \"NF1\", \"MPNST\"],\n    \"dataType\": [\"csv\", \"jpg\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"focus forming assay\", \"Matrigel-based tumorigenesis assay\"],\n    \"species\": [\"Mus musculus\"],\n    \"manifestation\": [\"Plexiform Neurofibroma\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"in vivo tumorigenesis\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"in vivo tumorigenesis\", \"TRAP1\", \"MPNST\"],\n    \"dataType\": [\"excel\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"in vitro tumorigenesis\"],\n    \"species\": [\"Mus musculus\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"mass spec data\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"mass spectrometry\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"AggregatedData\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"mass spectrometry\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  },\n  {\n    \"title\": \"mitochondrial ROS\",\n    \"creator\": [\"Andrea Rasola\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"mitochondrial ROS\", \"TRAP1\", \"NF1\"],\n    \"dataType\": [\"csv\"],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"reactive oxygen species assay\"],\n    \"species\": [\"Mus musculus\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\"Plexiform Neurofibroma\"]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7368, "completion_tokens": 2734, "total_tokens": 10102, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba735f08190b93e9ede43187cc1", "custom_id": "syn5610418", "response": {"status_code": 200, "request_id": "8bb251d8b00deb26f56511cba102bc36", "body": {"id": "chatcmpl-BHNWEqJieBxllJBI47Kl5Pwq3ed4Z", "object": "chat.completion", "created": 1743481682, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Synodos NF1 Patient WES Data (GSE145064)\",\n    \"creator\": [],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn5610418\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"WES Data Study\",\n    \"contributor\": [],\n    \"countryOfOrigin\": [],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": null,\n    \"description\": \"Whole Exome Sequencing (WES) data from 15 individuals with 46 specimens analyzed for Neurofibromatosis type 1, featuring Plexiform Neurofibroma and Malignant Peripheral Nerve Sheath Tumor types.\",\n    \"individualCount\": 15,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 46,\n    \"visualizeDataOn\": []\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4626, "completion_tokens": 284, "total_tokens": 4910, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba74a5c81908f6304ffe763b3fb", "custom_id": "syn8016599", "response": {"status_code": 200, "request_id": "b75a34c7bf0a5a08339b508b2d711825", "body": {"id": "chatcmpl-BHNWZvBfbiFJgloA5VLfbYTixCZb9", "object": "chat.completion", "created": 1743481703, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Kinome_Data\",\n    \"creator\": [\"Stephanie Bouley\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"MIB/MS\", \"kinomics\", \"proteomics\", \"NF1\", \"plexiform neurofibromas\"],\n    \"dataType\": [\"kinomics\"],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"MIB/MS\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"The dataset contains kinomic data generated using MIB/MS assays on human samples related to Neurofibromatosis type 1.\",\n    \"contributor\": [\"James Walker\", \"Stephanie Bouley\"]\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\"Stephanie Bouley\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"gene expression\", \"NF1\", \"plexiform neurofibromas\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"RNA-seq data for processing related to Neurofibromatosis type 1. The dataset aims to provide gene expression insights.\",\n    \"contributor\": [\"James Walker\", \"Stephanie Bouley\"]\n  },\n  {\n    \"title\": \"Proteomics_Data\",\n    \"creator\": [\"Stephanie Bouley\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"TMT quantitation\", \"proteomics\", \"NF1\", \"plexiform neurofibromas\"],\n    \"dataType\": [\"kinomics\"],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"TMT quantitation\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"Proteomics data utilizing TMT quantification to study kinomic profiles in NF1-associated samples.\",\n    \"contributor\": [\"James Walker\", \"Stephanie Bouley\"]\n  },\n  {\n    \"title\": \"RNAseq_Raw Data\",\n    \"creator\": [\"Stephanie Bouley\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"raw data\", \"gene expression\", \"NF1\", \"plexiform neurofibromas\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"description\": \"RNA-seq raw data for Neurofibromatosis type 1 research, focusing on gene expression analysis.\",\n    \"contributor\": [\"James Walker\", \"Stephanie Bouley\"]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6089, "completion_tokens": 772, "total_tokens": 6861, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba764008190b33096b9e234ed40", "custom_id": "syn4939910", "response": {"status_code": 200, "request_id": "d942a388568ce800f9211baa0536cde2", "body": {"id": "chatcmpl-BHNWeUAmq8baYnvBmE5F7y7TS5rWf", "object": "chat.completion", "created": 1743481708, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Copy Number Variant - CNVkit\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Copy Number Variant\", \"CNVkit\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn52299972\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"The dataset consists of copy number variant data processed using CNVkit. Contains example files like VA01.converted.cns, VA01.converted-scatter.png.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - DeepVariant Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"DeepVariant\", \"Whole Genome Sequencing\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn35562797\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Germline genomic variants identified using the DeepVariant pipeline. Species include Homo sapiens, with data available in VCF format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - FreeBayes Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"FreeBayes\", \"Whole Genome Sequencing\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn35562794\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Germline genomic variants identified using the FreeBayes pipeline. Species include Homo sapiens, with data available in VCF format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Mutect2 Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"Mutect2\", \"Whole Genome Sequencing\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn35562795\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Germline genomic variants identified using the Mutect2 pipeline. Species include Homo sapiens, with data available in VCF format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Strelka Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"Strelka\", \"Whole Genome Sequencing\"],\n    \"dataType\": [\"GermlineVariants\"],\n    \"studyId\": \"syn35562796\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Germline genomic variants identified using the Strelka pipeline. Species include Homo sapiens, with data available in VCF format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Metadata\",\n    \"creator\": [\"Benjamin Johnson\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Metadata\", \"Chromatin Activity\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn64954683\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Metadata related to chromatin activity with data in TXT format. Tumor types present include Cutaneous Neurofibroma.\",\n    \"tumor types present\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\"Steven Angus\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA Sequencing\", \"2023\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn51199012\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [],\n    \"description\": \"RNA sequencing data to be processed. Contains file types in FASTQ format.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSIprocessing-2022-26-04\",\n    \"creator\": [\"Matt\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA Sequencing\", \"Whole Genome Sequencing\", \"2022\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn29781479\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Whole genome sequencing focusing on NF1 with plexiform neurofibroma data. Available in FASTQ format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"specimenCount\": 0,\n    \"tumor types present\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Processed_beta_matrix\",\n    \"creator\": [\"Benjamin Johnson\", \"Sara Gosline\"],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Processed Data\", \"Beta Matrix\", \"Chromatin Activity\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn64954684\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Processed beta matrix data for chromatin activity. Data available in TXT format.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Raw_CNF_PNF_EPIC_idats\",\n    \"creator\": [\"Benjamin Johnson\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Raw Data\", \"Idats\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn64954685\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Raw data from CNF PNF using EPIC array. Data available in IDAT format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 38,\n    \"specimenCount\": 60,\n    \"tumor types present\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Van Andel - RNAseq and WXS\",\n    \"creator\": [\"Steven Angus\", \"Matt\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Van Andel\", \"RNA Sequencing\", \"WXS\"],\n    \"dataType\": [\"geneExpression\", \"genomicVariants\"],\n    \"studyId\": \"syn64954686\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Integrated RNA sequencing and whole genome sequencing data, focusing on NF1. Data available in FASTQ format.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"specimenCount\": 11,\n    \"tumor types present\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Whole Exome Sequencing of Mouse Samples\",\n    \"creator\": [\"Megan Bowman\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Exome Sequencing\", \"Mouse Samples\", \"Neurofibromatosis type 1\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn64954687\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Whole exome sequencing data of mouse samples focusing on Malignant Peripheral Nerve Sheath Tumor. Data available in FASTQ format.\",\n    \"species\": [\"Mus musculus\"],\n    \"individualCount\": 2,\n    \"specimenCount\": 7,\n    \"tumor types present\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7342, "completion_tokens": 2157, "total_tokens": 9499, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7793c8190b2af87b3f7c7dc47", "custom_id": "syn11374353", "response": {"status_code": 200, "request_id": "72cf2ef1b6edfa95f5b298be86660d17", "body": {"id": "chatcmpl-BHNWHXqZLnGmB6TRSjN0AGybDfqKx", "object": "chat.completion", "created": 1743481685, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"whole exome sequencing\", \"genomicVariants\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": [\"Bernat Gel Moreno\", \"Christina Parry\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": [\"Bernat Gel Moreno\", \"Helena Mazuelas\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"Other\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NF-OSI-processed-data\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"geneExpression\", \"AlignedReads\", \"Neurofibromatosis type 1\", \"Cutaneous Neurofibroma\"],\n    \"dataType\": [\"geneExpression\", \"AlignedReads\"],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\"Cutaneous Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"series\": \"NF-OSI Processed Data\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6209, "completion_tokens": 1105, "total_tokens": 7314, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba78ca081909da54a94d4c07950", "custom_id": "syn21650484", "response": {"status_code": 200, "request_id": "1184fe3486aa083db3576d8db0c61cdd", "body": {"id": "chatcmpl-BHNVmsvqTggRFN7Q0wgXsuORhOgrA", "object": "chat.completion", "created": 1743481654, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"Bulk RNA Sequencing Donor RGCs\",\n        \"creator\": [\n            \"Julia Oswald\",\n            \"Christina Parry\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RGC transplantation\",\n            \"stem cells\",\n            \"retinal ganglion cells\",\n            \"RNA sequencing\"\n        ],\n        \"dataType\": [\n            \"AlignedReads\"\n        ],\n        \"studyId\": \"syn21650484\",\n        \"diseaseFocus\": [],\n        \"funder\": [\n            \"GFF\"\n        ],\n        \"description\": \"This dataset includes bulk RNA sequencing data of donor retinal ganglion cells (RGCs) derived from mouse models for studying transplantation strategies and differentiation. The data aims at identifying key variables for optimizing RGC transplantation using stem cells.\",\n        \"measurementTechnique\": [\n            \"targeted exome sequencing\"\n        ],\n        \"species\": [\n            \"Mus musculus\"\n        ],\n        \"specimenCount\": 2,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4830, "completion_tokens": 244, "total_tokens": 5074, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba79f608190a6e181a8e9bb0aa8", "custom_id": "syn7231973", "response": {"status_code": 200, "request_id": "61616e914acebdce10184fde170beed7", "body": {"id": "chatcmpl-BHNVoG23nnMnZzsiipLyANYHxey8T", "object": "chat.completion", "created": 1743481656, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Exome\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"exome\", \"whole exome sequencing\", \"genomicVariants\", \"plexiform neurofibroma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset contains genomic variant data from whole exome sequencing of samples related to Plexiform Neurofibromas. It includes 9 individuals and 35 specimens from Homo sapiens.\",\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 9,\n    \"specimenCount\": 35,\n    \"manifestation\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-WES-To-Process-2023-15-03\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [],\n    \"funder\": [],\n    \"description\": \"This dataset is aimed at whole exome sequencing processing. Details about species, individuals, specimen count, and specific diagnoses are currently unspecified.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SNParray\",\n    \"creator\": [\"Bernat Gel Moreno\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"SNP array\", \"genomicVariants\", \"plexiform neurofibroma\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"This dataset contains SNP array data related to genomic variants in samples from Plexiform Neurofibromas. It includes 23 individuals and 40 specimens from Homo sapiens.\",\n    \"measurementTechnique\": [\"SNP array\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 23,\n    \"specimenCount\": 40,\n    \"manifestation\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5111, "completion_tokens": 580, "total_tokens": 5691, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7b1448190b6f5889edfb38bf4", "custom_id": "syn23651229", "response": {"status_code": 200, "request_id": "4725ade4fb554f3299a099d61c2f7665", "body": {"id": "chatcmpl-BHNVodgGsbXKhvAEmPTENk9pk1RqS", "object": "chat.completion", "created": 1743481656, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"Copy Number Variant - CNVkit\",\n        \"creator\": [\n            \"NF Service\",\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Copy Number Variant\",\n            \"Whole Genome Sequencing\",\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\",\n            \"clinical\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Ultra-low-pass whole genome sequencing of plasma cfDNA to distinguish between MPNST and PN in patients with NF1.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"manifestation\": [\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Germline Genomic Variants - DeepVariant Pipeline\",\n        \"creator\": [\n            \"NF Service\",\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Germline Genomic Variants\",\n            \"Whole Genome Sequencing\",\n            \"DeepVariant\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Whole genome sequencing of germline genomic variants using the DeepVariant pipeline.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Germline Genomic Variants - FreeBayes Pipeline\",\n        \"creator\": [\n            \"NF Service\",\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Germline Genomic Variants\",\n            \"Whole Genome Sequencing\",\n            \"FreeBayes\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Whole genome sequencing of germline genomic variants using the FreeBayes pipeline.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Germline Genomic Variants - Mutect2 Pipeline\",\n        \"creator\": [\n            \"NF Service\",\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Germline Genomic Variants\",\n            \"Whole Genome Sequencing\",\n            \"Mutect2\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Whole genome sequencing of germline genomic variants using the Mutect2 pipeline.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 42,\n        \"specimenCount\": 90,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Germline Genomic Variants - Strelka Pipeline\",\n        \"creator\": [\n            \"NF Service\",\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Germline Genomic Variants\",\n            \"Whole Genome Sequencing\",\n            \"Strelka\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Whole genome sequencing of germline genomic variants using the Strelka pipeline.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"NFOSIprocessing-2022-26-04\",\n        \"creator\": [\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Ultra-low-pass Whole Genome Sequencing\",\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\",\n            \"clinical\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Data processing for ultra-low-pass whole genome sequencing of patients with NF1.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"manifestation\": [\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"ULP Whole Genome Sequencing\",\n        \"creator\": [\n            \"Jack Shern, MD\",\n            \"Angela Hirbe, MD/PhD\",\n            \"Aadel Chaudhuri, MD/PhD\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Ultra-low-pass Whole Genome Sequencing\",\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"genomicVariants\",\n            \"clinical\",\n            \"metadata\"\n        ],\n        \"studyId\": \"syn23651229\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NIH-NCI\",\n            \"Independent\"\n        ],\n        \"description\": \"Ultra-low-pass whole genome sequencing data for differentiating between MPNST and PN in NF1 patients.\",\n        \"measurementTechnique\": [\n            \"whole genome sequencing\"\n        ],\n        \"species\": [\n            \"Homo sapiens\"\n        ],\n        \"individualCount\": 59,\n        \"specimenCount\": 117,\n        \"manifestation\": [\n            \"Plexiform Neurofibroma\",\n            \"Malignant Peripheral Nerve Sheath Tumor\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5863, "completion_tokens": 2037, "total_tokens": 7900, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7c3a48190aefecfdc7d379d29", "custom_id": "syn52740594", "response": {"status_code": 200, "request_id": "8be70081a5b91b0d60cae38db10f725f", "body": {"id": "chatcmpl-BHNVzNaCUmfmu4mXF6HpjG5W6XPiO", "object": "chat.completion", "created": 1743481667, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Minnesota CCHMC Recombinetics Team Data\",\n    \"creator\": [\n      \"Sue Rathe\",\n      \"Jon Hawkinson\",\n      \"Kyle Williams\",\n      \"Mike Mason\",\n      \"Robert Allaway\",\n      \"Nasim Sanati\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"conventional MRI\",\n      \"RNA-seq\",\n      \"cell viability assay\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn52740594\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset from the Minnesota CCHMC Recombinetics team includes data from assays like conventional MRI, RNA-seq, and cell viability assay, covering species Sus scrofa and Homo sapiens with emphases on Neurofibromatosis type 1 and associated tumor types.\",\n    \"measurementTechnique\": [\n      \"conventional MRI\",\n      \"RNA-seq\",\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Sus scrofa\",\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 20,\n    \"specimenCount\": 21,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\n      \"Sue Rathe\",\n      \"Jon Hawkinson\",\n      \"Kyle Williams\",\n      \"Mike Mason\",\n      \"Robert Allaway\",\n      \"Nasim Sanati\",\n      \"Sara Gosline\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4638, "completion_tokens": 453, "total_tokens": 5091, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7d5248190b047a73efbe52d2b", "custom_id": "syn18904024", "response": {"status_code": 200, "request_id": "ef12d8ae597ad7692aa1c31cad9247df", "body": {"id": "chatcmpl-BHNW2b2gh6bkXPwhV5K8LRB3fhrbw", "object": "chat.completion", "created": 1743481670, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\",\n        \"creator\": [\n            \"J. Elliott Robinson\",\n            \"Gerard M. Coughlin\",\n            \"Acacia M. Hori\",\n            \"Elisha D. Mackey\",\n            \"Jounhong Ryan Cho\",\n            \"Zeynep Turan\",\n            \"Tommaso Patriarchi\",\n            \"Lin Tian\",\n            \"Viviana Gradinaru\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"dopamine monitoring\",\n            \"dLight1\",\n            \"neurofibromatosis type 1\",\n            \"NF1\",\n            \"mouse model\",\n            \"mesolimbic phenotypes\",\n            \"dopaminergic circuitry\"\n        ],\n        \"dataType\": [\n            \"behavior process\",\n            \"electrophysiology\",\n            \"immunoassay\",\n            \"proteomics\"\n        ],\n        \"studyId\": \"syn18904024\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"CTF\"\n        ],\n        \"datePublished\": null,\n        \"description\": \"The dataset contains data from various assays including contextual conditioning behavior, in vivo bioluminescence, and whole-cell patch clamp to study dopaminergic neurotransmission in NF1 model mice.\",\n        \"measurementTechnique\": [\n            \"contextual conditioning behavior assay\",\n            \"in vivo bioluminescence\",\n            \"whole-cell patch clamp\",\n            \"immunofluorescence\",\n            \"HPLC\",\n            \"active avoidance learning behavior assay\",\n            \"novelty response behavior assay\"\n        ],\n        \"species\": [\n            \"Mus musculus\"\n        ],\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n        \"contributor\": [\n            \"Division of Biology and Biological Engineering, California Institute of Technology\",\n            \"Department of Biochemistry and Molecular Medicine, University of California, Davis\"\n        ]\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4852, "completion_tokens": 448, "total_tokens": 5300, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7e7108190849e294ac1838f60", "custom_id": "syn22267284", "response": {"status_code": 200, "request_id": "2a251452c61b81acab91e922940cb12f", "body": {"id": "chatcmpl-BHNW5axvAPp3iS0rP5lGHbuHqOt1i", "object": "chat.completion", "created": 1743481673, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"20201125-ipNF0.23 and ipnF05.5 O-glycosylation\",\n    \"creator\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"glycosylation\", \"proteomics\", \"Neurofibromatosis type 1\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"mass spectrometry\"],\n    \"specimenCount\": 2,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NF1 Proteomics\",\n    \"creator\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"proteomics\", \"Neurofibromatosis type 1\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"CTF\"],\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"mass spectrometry\"],\n    \"specimenCount\": 2,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Neurofibromin Immunoprecipitation 20201123\",\n    \"creator\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"immunoprecipitation\", \"proteomics\", \"Homo sapiens\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [],\n    \"funder\": [\"CTF\"],\n    \"contributor\": [\"Kevin Bruemmer\", \"Anh Nguyet Vu\"],\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"mass spectrometry\"],\n    \"specimenCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5140, "completion_tokens": 579, "total_tokens": 5719, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba7f9fc8190ae0c37edada3e7c5", "custom_id": "syn4939878", "response": {"status_code": 200, "request_id": "eca016d054ca71233f1d8b370b695d26", "body": {"id": "chatcmpl-BHNW9eqeSMPEi8qXg4rTkplbs2kx6", "object": "chat.completion", "created": 1743481677, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"PRO Reports\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"PRO Reports\",\n      \"Pediatric Quality of Life Inventory\",\n      \"PedsQL\",\n      \"Neurofibromatosis Type 1\",\n      \"Survey Data\",\n      \"Questionnaire\"\n    ],\n    \"dataType\": [\n      \"surveyData\"\n    ],\n    \"studyId\": \"syn4939878\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"PRO Reports dataset aims to develop a Pediatric Quality of Life Inventory for Neurofibromatosis Type 1 (NF1) through survey data collected via questionnaires.\",\n    \"contributor\": [\n      \"Nancy Swigonski, MD, MPH\",\n      \"Kavitha Nutakki, MBBS, MPH\"\n    ],\n    \"measurementTechnique\": [\n      \"questionnaire\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4943, "completion_tokens": 271, "total_tokens": 5214, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba80e4481909f07fe637db2a9a5", "custom_id": "syn11681835", "response": {"status_code": 200, "request_id": "43e03cc9c414ddbdbdadd78d3e26846f", "body": {"id": "chatcmpl-BHNWBxY2jKWPBJBCs5zmkaGMOQJrJ", "object": "chat.completion", "created": 1743481679, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"NF-OSI-processed-data\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Novel Therapeutics\",\n      \"NF1-associated MPNST\",\n      \"PRC2\",\n      \"CDKN2A\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"RNA-seq\",\n      \"single-cell RNA-seq\",\n      \"Neurofibromatosis type 1\",\n      \"geneExpression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"funder\": [],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": [\n      \"RNA-seq\",\n      \"single-cell RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 41,\n    \"specimenCount\": 41\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5903, "completion_tokens": 406, "total_tokens": 6309, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8235c8190b3f35cdb0757358b", "custom_id": "syn26238842", "response": {"status_code": 200, "request_id": "33f7945ce447b6a5c8352bb806b6bc00", "body": {"id": "chatcmpl-BHNWEKbvsZlNvbjnpWkkFnQplgGHh", "object": "chat.completion", "created": 1743481682, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Trial Run HscWT and Hsc45 Proteomics\",\n    \"creator\": [\n      \"Maria C. Franco\",\n      \"Isabelle E. Logan\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 2\",\n      \"Proteomics\",\n      \"Signaling pathways\",\n      \"Nitrated proteins\",\n      \"Tumor-directed therapies\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn26238842\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"Hsc Proteomics\",\n    \"description\": \"This dataset explores the role of nitrated proteins in the pathogenesis of Neurofibromatosis type 2 by analyzing proteomics data from experimental trials.\",\n    \"contributor\": [\n      \"Isabelle E. Logan\"\n    ],\n    \"creator\": [\n      \"Maria C. Franco\",\n      \"Isabelle E. Logan\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4834, "completion_tokens": 272, "total_tokens": 5106, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba837b88190a0a90898d7a6cd61", "custom_id": "syn11374354", "response": {"status_code": 200, "request_id": "5f1f47ea4973c494fbbb54cec0557a9d", "body": {"id": "chatcmpl-BHNWHS00SuGMXmdUbH1AZhKtVFCja", "object": "chat.completion", "created": 1743481685, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"cNF 12 Months Deliverable\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ],\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"This dataset contains immunohistochemistry images of patient-derived cutaneous neurofibroma specimens used for therapeutic screenings.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 9,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"immunohistochemistry\",\n      \"cutaneous neurofibroma\",\n      \"drug screening\",\n      \"tif\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"specimenCount\": 76,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"cNF 6 Months Deliverables\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ],\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"This dataset contains images related to staining protocols for analyzing cutaneous neurofibroma specimens.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 1,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"immunohistochemistry\",\n      \"cutaneous neurofibroma\",\n      \"staining protocol\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"specimenCount\": 2,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"Aligned Reads from RNA-seq\",\n    \"contributor\": [\n      \"Orca Service\"\n    ],\n    \"creator\": [\n      \"Orca Service\"\n    ],\n    \"dataType\": [\n      \"dataIndex\",\n      \"AlignedReads\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Aligned reads dataset from RNA-seq analysis of cutaneous neurofibroma organoid models.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"UNKNOWN\"\n    ],\n    \"individualCount\": 5,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"aligned reads\",\n      \"cutaneous neurofibroma\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 54,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"Gene Expression Quantification\",\n    \"contributor\": [\n      \"Orca Service\"\n    ],\n    \"creator\": [\n      \"Orca Service\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Gene expression quantification from RNA-seq in cutaneous neurofibroma organoid models.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"UNKNOWN\"\n    ],\n    \"individualCount\": 5,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"cutaneous neurofibroma\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 55,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"NF Organoid Bisulfite-seq\",\n    \"contributor\": [\n      \"UNKNOWN\"\n    ],\n    \"creator\": [\n      \"UNKNOWN\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Bisulfite sequencing data of cutaneous neurofibroma organoid models.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 5,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"bisulfite sequencing\",\n      \"chromatin activity\",\n      \"cutaneous neurofibroma\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"bisulfite sequencing\"\n    ],\n    \"specimenCount\": 55,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"NF Organoid RNA-seq\",\n    \"contributor\": [\n      \"UNKNOWN\"\n    ],\n    \"creator\": [\n      \"UNKNOWN\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"RNA-seq data of NF organoids for gene expression analysis.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 5,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"NF organoids\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 57,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ],\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"RNA-seq dataset for NFOSI project focusing on gene expression of cutaneous neurofibroma.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 5,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"NFOSI\",\n      \"cutaneuos neurofibroma\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 57,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"RNASeq - Failed QC\",\n    \"contributor\": [\n      \"Alice Soragni\",\n      \"Sara Gosline\"\n    ],\n    \"creator\": [\n      \"Alice Soragni\",\n      \"Sara Gosline\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"RNA-seq data containing samples that failed quality control during assessment of cutaneous neurofibroma.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 2,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"failed QC\",\n      \"cutaneous neurofibroma\",\n      \"Homo sapiens\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 6,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"title\": \"A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6323, "completion_tokens": 2331, "total_tokens": 8654, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba84e108190a068a71529cf7cf4", "custom_id": "syn28545963", "response": {"status_code": 200, "request_id": "9a5088108a0b18a1c3e1376335b9cd52", "body": {"id": "chatcmpl-BHNWT2azsanZn84truMiX6YPPcHdV", "object": "chat.completion", "created": 1743481697, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here's the curated metadata for the datasets based on the given information and following the JSON schema you've provided:\n\n```json\n[\n  {\n    \"title\": \"Viral Counts (CTAT-VIF)\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Virus Detection\", \"Schwannomatosis\", \"Genomic Analysis\"],\n    \"dataType\": [],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\"Schwannomatosis-NOS\"],\n    \"funder\": [\"CTF\"],\n    \"alternateName\": \"Virus Detection Counts Data\",\n    \"description\": \"This dataset contains viral read counts summary for Schwannomatosis patients, created using VirusDetect.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"conditionsOfAccess\": \"Must complete the Synapse registration, certification quiz, user profile setup, and request file access.\",\n    \"species\": [],\n    \"individualCount\": null,\n    \"specimenCount\": null\n  },\n  {\n    \"title\": \"WES\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Exome Sequencing\", \"Genomics\", \"Schwannomatosis\"],\n    \"dataType\": [\"whole exome sequencing\"],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\"Schwannomatosis-NOS\"],\n    \"funder\": [\"CTF\"],\n    \"alternateName\": \"Exome Sequencing Data\",\n    \"description\": \"Whole Exome Sequencing (WES) data for Schwannomatosis research.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"conditionsOfAccess\": \"Must complete the Synapse registration, certification quiz, user profile setup, and request file access.\",\n    \"species\": [],\n    \"individualCount\": null,\n    \"specimenCount\": null\n  }\n]\n```\n\n**Notes:**\n- For fields such as `dataType`, `species`, `individualCount`, and `specimenCount`, the values are left empty (`[]` or `null`) due to lack of specific information. If more information becomes available, these fields should be updated accordingly.\n- Assumptions such as setting `accessType` to \"Controlled Access\" are based on the provided steps and requirements for data access.\n- As the specific keywords for the datasets were not provided, general terms related to the dataset context are used. Adjust these based on more detailed data if needed.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5859, "completion_tokens": 552, "total_tokens": 6411, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba861ec81909c3947d3177099a4", "custom_id": "syn4939892", "response": {"status_code": 200, "request_id": "12d6960e99bab79b8efda5cf85a88d0e", "body": {"id": "chatcmpl-BHNWYCRYVyqGA7CCK4TsKUV0IGHUW", "object": "chat.completion", "created": 1743481702, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Gene Expression for Identification of Neurofibroma Growth and Drug Resistance Pathways\",\n    \"creator\": [\n      \"Kwangmn Choi\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Plexiform Neurofibroma\",\n      \"Neurofibromatosis type 1\",\n      \"Gene Expression\",\n      \"RNA-seq\",\n      \"Mus musculus\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939892\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"The dataset focuses on gene expression analysis using RNA-seq to identify pathways related to neurofibroma growth and drug resistance, with specific emphasis on plexiform neurofibromas. The study utilizes mouse models to mimic human neurofibromas.\",\n    \"contributor\": [\n      \"Nancy Ratner, Ph.D.\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": 2,\n    \"specimenCount\": 2,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"datePublished\": 2016\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5131, "completion_tokens": 329, "total_tokens": 5460, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba876ac8190aa5f8ff2c9be3aac", "custom_id": "syn51133946", "response": {"status_code": 200, "request_id": "23eaa93f6114187b71174d7661507bac", "body": {"id": "chatcmpl-BHNWcvD3VLldBRJbn9hksCwKMh51F", "object": "chat.completion", "created": 1743481706, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"ADVL1521 Omic Data Repository\",\n    \"creator\": [\n      \"Kevin Shannon\",\n      \"Mignon Loh\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"single-cell RNA-seq\",\n      \"Homo sapiens\",\n      \"Juvenile Myelomonocytic Leukemia\",\n      \"geneExpression\",\n      \"fastq\",\n      \"NIH-NCI\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn51133946\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"description\": \"This dataset contains single-cell RNA-seq data from Homo sapiens associated with juvenile myelomonocytic leukemia, specifically focusing on gene expression studies. It's part of a clinical trial analyzing the MEK inhibitor Trametinib.\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 7,\n    \"specimenCount\": 14,\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4888, "completion_tokens": 287, "total_tokens": 5175, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba88ae48190a05b0b221418457f", "custom_id": "syn4939918", "response": {"status_code": 200, "request_id": "0c668243fd434502135b15ee951f5ef1", "body": {"id": "chatcmpl-BHNWeVcNUvjYLMnOHqcwPqCGPOMAg", "object": "chat.completion", "created": 1743481708, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"gene expression\",\n      \"RNA-seq\",\n      \"iPS cells\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn51930713\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Quantification of gene expression using RNA-seq for PNF-derived NF1(+/-) and NF1(-/-) iPS cells, aimed at understanding the origins and progression of plexiform neurofibromas.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"MethylationArray\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation\",\n      \"Chromatin activity\",\n      \"iPS cells\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn64954688\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"This dataset includes methylation array data, focusing on chromatin activity in Neurofibromatosis type 1 derived iPS cells to study epigenetic modifications.\",\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"iPS cells\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn51198953\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"RNA sequencing data for NF1 related studies, focusing on gene expression in iPS cells to understand neurofibroma development.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"RNAseq\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"iPS cells\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn64954689\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"RNAseq dataset focused on gene expression profiling in Neurofibromatosis type 1 derived iPS cells for developmental insights.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"SNParray\",\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SNP array\",\n      \"genomic variants\",\n      \"iPS cells\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn64954690\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"SNP array data providing genomic variant information for iPS cells from Neurofibromatosis type 1 studies to understand genetic contributions to disease.\",\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5601, "completion_tokens": 1116, "total_tokens": 6717, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba89cb48190a6110cc630d9114a", "custom_id": "syn7239560", "response": {"status_code": 200, "request_id": "c09f471f954db1bb8c306e60d151c636", "body": {"id": "chatcmpl-BHNWl7ylMeDelmIQiM6EyC7z2zt5H", "object": "chat.completion", "created": 1743481715, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Here is the curated dataset metadata conforming to the provided JSON schema:\n\n```json\n[\n  {\n    \"title\": \"Compound Annotations from Evotec Drug Target Research\",\n    \"creator\": [\n      \"Tim James\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"compound annotations\",\n      \"drug target research\",\n      \"Evotec\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn7239560\",\n    \"diseaseFocus\": [],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"The dataset contains various annotations of compounds involved in Evotec Drug Target Research. It includes compound structure data, annotations, and associated file formats like doc, sdf, csv, and txt.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"series\": \"NF-OSI Processed Data\"\n  }\n]\n```\n\n### Notes:\n- Since no specific data types or disease focus were mentioned for the table, those are left empty.\n- Assumptions and default values have been applied where necessary based on provided schema guidance.\n- If the dataset were to include specific measurement techniques, diseases, or phenotypes, and had known individual or specimen counts or was part of a study with conditions of access, these would need to be filled in appropriately.", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4450, "completion_tokens": 293, "total_tokens": 4743, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8ae9c8190a398e9cd180d3b55", "custom_id": "syn4939906", "response": {"status_code": 200, "request_id": "93b1150375c7f5037954dc8c2f336813", "body": {"id": "chatcmpl-BHNWoYGSjB8WQoSNdG3iFsMoKNy64", "object": "chat.completion", "created": 1743481718, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"10x10 Combination Screens of pNF Cell Lines\",\n    \"creator\": [\"Marc Ferrer, Ph.D.\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability assay\", \"drug combination\", \"pNF\"],\n    \"dataType\": [\"drugCombinationScreen\"],\n    \"studyId\": \"syn4939906\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Screening of pNF cell lines using 10x10 combination assays to identify optimal therapeutic combinations for plexiform neurofibromas.\",\n    \"contributor\": [\"NTAP\"],\n    \"individualCount\": 4,\n    \"specimenCount\": 4,\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"cell viability assay\"],\n    \"manifestation\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6x6 Combination Screens of pNF Cell Lines\",\n    \"creator\": [\"Marc Ferrer, Ph.D.\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability assay\", \"drug combination\", \"pNF\"],\n    \"dataType\": [\"drugCombinationScreen\"],\n    \"studyId\": \"syn4939906\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Screening of pNF cell lines using 6x6 combination assays to explore potential therapeutic synergies for plexiform neurofibromas.\",\n    \"contributor\": [\"NTAP\"],\n    \"individualCount\": 6,\n    \"specimenCount\": 6,\n    \"species\": [\"Homo sapiens\"],\n    \"measurementTechnique\": [\"cell viability assay\"],\n    \"manifestation\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Single Agent Screens of pNF Cell Lines\",\n    \"creator\": [\"Marc Ferrer, Ph.D.\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"cell viability assay\", \"drug screening\", \"pNF\"],\n    \"dataType\": [\"drugScreen\"],\n    \"studyId\": \"syn4939906\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\"],\n    \"description\": \"Single agent screening of pNF cell lines to identify promising drug candidates with high potency and efficacy for plexiform neurofibromas.\",\n    \"contributor\": [\"NTAP\"],\n    \"individualCount\": 11,\n    \"specimenCount\": 11,\n    \"species\": [\"Homo sapiens\", \"Mus musculus\"],\n    \"measurementTechnique\": [\"cell viability assay\"],\n    \"manifestation\": [\"Plexiform Neurofibroma\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5458, "completion_tokens": 678, "total_tokens": 6136, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8c1f88190849d846da81c084f", "custom_id": "syn53185180", "response": {"status_code": 200, "request_id": "97f3b7c3940f94499f0545a0899ea959", "body": {"id": "chatcmpl-BHNWtPSbTV3bIFUt97lzwdfpo0KfW", "object": "chat.completion", "created": 1743481723, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Colony forming assays\",\n    \"creator\": [\n      \"Raymond Mattingly\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Colony formation\",\n      \"NF1\",\n      \"MPNST\",\n      \"Farnesyltransferase\",\n      \"Lovastatin\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn53185180\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\",\n      \"Other\"\n    ],\n    \"description\": \"Synergistic suppression of NF1 malignant peripheral nerve sheath tumor cell growth using combinational treatments with statins and prodrugs.\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"creator\": [\n      \"Raymond Mattingly\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4596, "completion_tokens": 275, "total_tokens": 4871, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8d55081909ef23028a2236324", "custom_id": "syn20608511", "response": {"status_code": 200, "request_id": "58edcfbc3dd0e87a84d67db63dba4b20", "body": {"id": "chatcmpl-BHNWvOezwXepquYrqgAqhkQnHsGnO", "object": "chat.completion", "created": 1743481725, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Whole Body MRI of NF Patients\",\n    \"creator\": [\n      \"Robert Allaway\",\n      \"Jineta Banerjee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole-body MRI\",\n      \"NF1\",\n      \"NF2\",\n      \"Schwannomatosis\",\n      \"conventional MRI\",\n      \"clinical data\",\n      \"DICOM\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"clinical\"\n    ],\n    \"studyId\": \"syn20608511\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"NF2-related schwannomatosis\",\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"Whole-body MRI datasets for NF diagnosis and tracking\",\n    \"contributor\": [\n      \"Dr. Wenli Cai\",\n      \"Dr. Gordon Harris\"\n    ],\n    \"creator\": [\n      \"Massachusetts General Hospital (MGH)\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"This dataset comprises whole-body MRI images in STIR and T1 modalities from 48 NF1, NF2, and schwannomatosis patients. It includes clinical metadata for tumor burden analysis and is curated for volumetric image analysis.\",\n    \"individualCount\": 9,\n    \"specimenCount\": 9,\n    \"countryOfOrigin\": [\n      \"USA\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": [\n      \"conventional MRI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4766, "completion_tokens": 391, "total_tokens": 5157, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8e72c8190a71fc86cc24352b0", "custom_id": "syn51133914", "response": {"status_code": 200, "request_id": "90acb2ab7598f3ec7318a297985f4307", "body": {"id": "chatcmpl-BHNX143XxNz8NnefpNgS6SJBEDpbs", "object": "chat.completion", "created": 1743481731, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Histopathology - Human PN, ANNUBP and MPNST Specimens\",\n    \"creator\": [\n      \"Steven Rhodes\",\n      \"Andrew Horvai\",\n      \"Elliot Stieglitz\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Histopathology\",\n      \"Plexiform Neurofibroma\",\n      \"Neurofibromatosis\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Human Specimens\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn51133914\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"description\": \"This dataset comprises histopathology images (svs, xml) of human specimens with diagnoses such as Plexiform Neurofibroma and Malignant Peripheral Nerve Sheath Tumor. It includes data from various tumor types and provides critical insights for NF1-related research.\",\n    \"contributor\": [\n      \"Steven Rhodes\",\n      \"Andrew Horvai\",\n      \"Elliot Stieglitz\"\n    ],\n    \"countryOfOrigin\": [\n      \"USA\"\n    ],\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 30,\n    \"specimenCount\": 61,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Aneurysmal Bone Cyst (ANNUBP)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"yearProcessed\": null\n  },\n  {\n    \"title\": \"Van Andel - Kinome\",\n    \"creator\": [\n      \"Steven Angus\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Kinome\",\n      \"Neurofibromatosis type 1\",\n      \"Proteomics\",\n      \"Van Andel Institute\",\n      \"Kinomics\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn51133914\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"description\": \"This dataset includes kinomics data for understanding NF1 using specimens from 16 individuals. It is crucial for examining the proteomic landscape in NF1-related tumor studies and advancing clinical research.\",\n    \"contributor\": [\n      \"Steven Angus\",\n      \"Sara Gosline\"\n    ],\n    \"individualCount\": 16,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"yearProcessed\": null\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5070, "completion_tokens": 645, "total_tokens": 5715, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba8f9248190bb0441928b233b50", "custom_id": "syn22268639", "response": {"status_code": 200, "request_id": "ddd7d35858743c034ca90269a76f2ce5", "body": {"id": "chatcmpl-BHNX5qS8RGIeAB78C6W0Mli5vTwVn", "object": "chat.completion", "created": 1743481735, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"P2RY14 and NF1\",\n    \"creator\": [\n      \"Jennifer Patritti Cram\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"P2RY14\",\n      \"Neurofibroma\",\n      \"Western blot\",\n      \"Immunoassay\",\n      \"Human\",\n      \"Mouse\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn22268639\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"This dataset examines the role of P2RY14 in the formation of tumors in Neurofibromatosis Type 1 using western blot assays. The investigation involves both human and humanized mouse models.\",\n    \"contributor\": [\n      \"Jennifer Patritti Cram\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus (humanized)\"\n    ],\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"individualCount\": null,\n    \"specimenCount\": null,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5594, "completion_tokens": 303, "total_tokens": 5897, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba90b908190bb21c73dc84ca0de", "custom_id": "syn32128792", "response": {"status_code": 200, "request_id": "4aed19e34d8f5d47c7407bd3a4c32109", "body": {"id": "chatcmpl-BHNX8T1gRT9xBSFdOcDZCjCyVKQzP", "object": "chat.completion", "created": 1743481738, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"EGA Raw Data (requires approval on EGA)\",\n    \"creator\": [\n      \"NFRI - Genomics of MPNST (GeM) Consortium\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"geneExpression\",\n      \"fastq\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn32128792\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"alternateName\": \"syn38299187\",\n    \"conditionsOfAccess\": \"You must request permission and access the data on EGA.\",\n    \"contributor\": [\n      \"Boston Children's Hospital\"\n    ],\n    \"countryOfOrigin\": [\n      \"USA\"\n    ],\n    \"dataUseModifiers\": [\n      \"Ethics Approval Required\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"This dataset consists of raw genomic data for MPNST research, requiring access approval via EGA.\",\n    \"individualCount\": 79,\n    \"keywords\": [\n      \"Genomics\",\n      \"MPNST\",\n      \"Gene Expression\",\n      \"Raw Data\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 139,\n    \"species\": [\n      \"Homo sapiens\"\n    ]\n  },\n  {\n    \"title\": \"EGAD00001008608 RNA-Seq Processed Data - quant.genes.sf (requires approval on EGA)\",\n    \"creator\": [\n      \"NFRI - Genomics of MPNST (GeM) Consortium\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"RNA-seq\",\n      \"Processed Data\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn32128792\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"alternateName\": \"syn38893832\",\n    \"conditionsOfAccess\": \"You must request permission and access the data on EGA.\",\n    \"contributor\": [\n      \"Boston Children's Hospital\"\n    ],\n    \"dataUseModifiers\": [\n      \"Ethics Approval Required\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"RNA-Seq processed data in quant.genes.sf format, available via EGA with access permissions.\",\n    \"individualCount\": 79,\n    \"specimenCount\": 139,\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ]\n  },\n  {\n    \"title\": \"EGAD00001008608 RNA-Seq Processed Data - quant.sf (requires approval on EGA)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"RNA-seq\",\n      \"Processed Data\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn32128792\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"alternateName\": \"syn58895011\",\n    \"conditionsOfAccess\": \"You must request permission and access the data on EGA.\",\n    \"contributor\": [\n      \"Boston Children's Hospital\"\n    ],\n    \"dataUseModifiers\": [\n      \"Ethics Approval Required\"\n    ],\n    \"datePublished\": 2023,\n    \"description\": \"Processed RNA-Seq data in quant.sf format for MPNST research, requiring EGA access permissions.\",\n    \"individualCount\": 79,\n    \"specimenCount\": 139,\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4954, "completion_tokens": 1004, "total_tokens": 5958, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba91d988190b4f53dbdf1846792", "custom_id": "syn22268689", "response": {"status_code": 200, "request_id": "a140ac898d8537a94954ebd147423977", "body": {"id": "chatcmpl-BHNXFPktQ9ickbtfRtrdOaMhxSspd", "object": "chat.completion", "created": 1743481745, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Proteomics\",\n    \"creator\": [\"Aram Ko\", \"James Moon\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Proteomics\", \"Mass Spectrometry\", \"TMT Quantitation\", \"Glioblastoma\"],\n    \"dataType\": [\"proteomics\"],\n    \"studyId\": \"syn22268689\",\n    \"diseaseFocus\": [\"LZTR1-related schwannomatosis\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset contains proteomics data from mass spectrometry and TMT quantitation assays focused on Glioblastoma and related tumors using samples from Mus musculus and Homo sapiens.\",\n    \"contributor\": [\"Aram Ko\", \"James Moon\"],\n    \"species\": [\"Mus musculus\", \"Homo sapiens\"],\n    \"specimenCount\": 1,\n    \"tumorTypes\": [\"Glioblastoma\"],\n    \"measurementTechnique\": [\"mass spectrometry\", \"TMT quantitation\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"countryOfOrigin\": []\n  },\n  {\n    \"title\": \"in vitro viability assay\",\n    \"creator\": [\"Aram Ko\", \"James Moon\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"In Vitro\", \"Viability Assay\", \"Drug Combination Screen\"],\n    \"dataType\": [\"drugCombinationScreen\"],\n    \"studyId\": \"syn22268689\",\n    \"diseaseFocus\": [\"LZTR1-related schwannomatosis\"],\n    \"funder\": [\"CTF\"],\n    \"description\": \"This dataset includes data from in vitro viability assays conducted on Mus musculus samples, focusing on drug combination screens.\",\n    \"contributor\": [\"Aram Ko\", \"James Moon\"],\n    \"species\": [\"Mus musculus\"],\n    \"measurementTechnique\": [\"cell viability assay\"],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"countryOfOrigin\": []\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5416, "completion_tokens": 447, "total_tokens": 5863, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba92eb48190aaf6566c2ce0e3ef", "custom_id": "syn11374345", "response": {"status_code": 200, "request_id": "9eb3e2056e7d23b14f801432c81814fa", "body": {"id": "chatcmpl-BHNXJI2s9i40audrXTOz0Z7cnrcde", "object": "chat.completion", "created": 1743481749, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"immunofluorescence\",\n      \"real-time PCR\",\n      \"geneExpression\",\n      \"image\",\n      \"metadata\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\n      \"Corina Anastasaki\"\n    ]\n  },\n  {\n    \"title\": \"18 month deliverables - Jan 2020\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunocytochemistry\",\n      \"real-time PCR\",\n      \"geneExpression\",\n      \"image\",\n      \"metadata\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunocytochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\n      \"Corina Anastasaki\",\n      \"Christina Parry\"\n    ]\n  },\n  {\n    \"title\": \"30 month deliverables - December 2020\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"local field potential recording\",\n      \"array\",\n      \"cell proliferation\",\n      \"cell count\",\n      \"western blot\",\n      \"immunocytochemistry\",\n      \"immunohistochemistry\",\n      \"electrophysiology\",\n      \"image\",\n      \"raw counts\",\n      \"metadata\",\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"dataType\": [\n      \"electrophysiology\",\n      \"image\",\n      \"raw counts\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"local field potential recording\",\n      \"array\",\n      \"cell proliferation\",\n      \"cell count\",\n      \"western blot\",\n      \"immunocytochemistry\",\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunocytochemistry\",\n      \"western blot\",\n      \"quantitative PCR\",\n      \"image\",\n      \"Neurofibromatosis type 1\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"metadata\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunocytochemistry\",\n      \"western blot\",\n      \"quantitative PCR\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"specimenCount\": 2\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5474, "completion_tokens": 945, "total_tokens": 6419, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba93f348190b5b20b212651ea27", "custom_id": "syn9727752", "response": {"status_code": 200, "request_id": "b674ffab79227ebbbccc2836d6d643a7", "body": {"id": "chatcmpl-BHNXOH4ZivCZgILNAjKcMP8eqI19F", "object": "chat.completion", "created": 1743481754, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Deep Variant Tumor Calls\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": []\n  },\n  {\n    \"title\": \"Methylation\",\n    \"creator\": [\"Sheila Mansouri\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"methylation\", \"epigenomics\", \"chromatin activity\"],\n    \"dataType\": [\"chromatinActivity\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"methylation array\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 45,\n    \"specimenCount\": 91,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"RNAseq\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA sequencing\", \"gene expression\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 14,\n    \"specimenCount\": 24,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"SWNTS_processing_2020-05-13\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": []\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Raw Data (NF-OSI Merged fastq)\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"raw data\", \"merged fastq\"],\n    \"dataType\": [],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 14,\n    \"specimenCount\": 24,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Raw Data (Unmerged, Original fastq)\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [],\n    \"dataType\": [],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": []\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq quant.sf files\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"RNA-seq\", \"quantification\", \"sf files\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"RNA-seq\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 14,\n    \"specimenCount\": 22,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"Somatic Mutations\",\n    \"creator\": [],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"somatic mutations\"],\n    \"dataType\": [],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"]\n  },\n  {\n    \"title\": \"Somatic Variants - Strelka - WES\",\n    \"creator\": [\"Sasha Scott\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Somatic Variants\", \"Strelka\", \"WES\"],\n    \"dataType\": [\"SomaticVariants\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"specimenCount\": 40,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"Whole genome sequencing\",\n    \"creator\": [\"Robert Allaway\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"WGS\", \"genomic variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 8,\n    \"specimenCount\": 18,\n    \"manifestation\": [\"Schwannoma\"]\n  },\n  {\n    \"title\": \"whole exome sequencing\",\n    \"creator\": [\"Fulvio D'Angelo\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"WES\", \"genomic variants\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\"CTF\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 38,\n    \"specimenCount\": 91,\n    \"manifestation\": [\"Schwannoma\"]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 6511, "completion_tokens": 1404, "total_tokens": 7915, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba95144819080b776ae751136ed", "custom_id": "syn4939916", "response": {"status_code": 200, "request_id": "91dba3c2ba0b639f5f010fe9ca7f9b7f", "body": {"id": "chatcmpl-BHNXWt09mwhVAt19QhSlI3IlGqWzq", "object": "chat.completion", "created": 1743481762, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Screening of Plexiform Neurofibroma Models in 96-well Format\",\n    \"creator\": [\n      \"Raymond Mattingly, Ph.D.\",\n      \"Markiesha Baines\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Plexiform Neurofibroma\",\n      \"3D Models\",\n      \"Drug Screening\",\n      \"Cell Viability Assay\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn4939916\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"This dataset supports the project goals to test drug sensitivity in 96-well format using 3D models of Plexiform Neurofibromas. It compares 2D and 3D assay results for potential clinical prediction of drug effectiveness.\",\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"contributor\": [\n      \"Raymond Mattingly, Ph.D.\",\n      \"Markiesha Baines\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ]\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4969, "completion_tokens": 311, "total_tokens": 5280, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9647c81909b105a0065f84bb1", "custom_id": "syn11374333", "response": {"status_code": 200, "request_id": "67729ef84770e6cfb02995cc81b4a76d", "body": {"id": "chatcmpl-BHNVpr18xfxHoVLYXGg0om1eQq5dB", "object": "chat.completion", "created": 1743481657, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\n      \"Lu Le\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunofluorescence\",\n      \"image\",\n      \"tif\",\n      \"Lu Le\",\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"specimenCount\": 1,\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": [\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunofluorescence\",\n      \"tif\",\n      \"Lu Le\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": [\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunofluorescence\",\n      \"brightfield microscopy\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"immunocytochemistry\",\n      \"western blot\",\n      \"image\",\n      \"geneExpression\",\n      \"NTAP\",\n      \"Lu Le\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"tumorTypes\": [\n      \"Teratoma\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\",\n      \"brightfield microscopy\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"immunocytochemistry\",\n      \"western blot\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": [\n      \"Renee McKay\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunohistochemistry\",\n      \"reporter gene assay\",\n      \"brightfield microscopy\",\n      \"immunofluorescence\",\n      \"cell count\",\n      \"whole exome sequencing\",\n      \"geneExpression\",\n      \"image\",\n      \"jpg\",\n      \"Renee McKay\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"tumorTypes\": [\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\",\n      \"reporter gene assay\",\n      \"brightfield microscopy\",\n      \"immunofluorescence\",\n      \"cell count\",\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"diagnosesPresent\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\n      \"Lu Le\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"immunofluorescence\",\n      \"image\",\n      \"jpg\",\n      \"Lu Le\",\n      \"Robert Allaway\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"specimenCount\": 1,\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"diagnosesPresent\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5685, "completion_tokens": 1139, "total_tokens": 6824, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9772c8190bb4562964054d3d2", "custom_id": "syn21650493", "response": {"status_code": 200, "request_id": "f5b47048a8350d9a76779713cb5dc5e6", "body": {"id": "chatcmpl-BHNVvWOghIWQncpggAANN6rUdpVAE", "object": "chat.completion", "created": 1743481663, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"AAV Ascl1 v YapS5A EdU\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"immunofluorescence\", \"Mus musculus\", \"raw counts\"],\n        \"dataType\": [\"raw counts\"],\n        \"studyId\": \"syn64954827\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"immunofluorescence\"],\n        \"species\": [\"Mus musculus\"]\n    },\n    {\n        \"title\": \"AAV Ascl1 v YapS5A EdU image\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"immunofluorescence\", \"Mus musculus\", \"immunoassay\"],\n        \"dataType\": [\"immunoassay\"],\n        \"studyId\": \"syn64954828\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"immunofluorescence\"],\n        \"species\": [\"Mus musculus\"]\n    },\n    {\n        \"title\": \"ATACseq Ascl1a lin28a OE v control uninj Muller glia\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"ATAC-seq\", \"Danio rerio\", \"chromatinActivity\"],\n        \"dataType\": [\"chromatinActivity\"],\n        \"studyId\": \"syn64954829\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"ATAC-seq\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 4,\n        \"specimenCount\": 5\n    },\n    {\n        \"title\": \"ATACseq DAPT v DMSO\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"ATAC-seq\", \"Danio rerio\", \"raw counts\"],\n        \"dataType\": [\"raw counts\"],\n        \"studyId\": \"syn64954830\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"ATAC-seq\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 1,\n        \"specimenCount\": 1\n    },\n    {\n        \"title\": \"ATACseq inj v uninj\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"ATAC-seq\", \"raw counts\", \"Danio rerio\"],\n        \"dataType\": [\"raw counts\"],\n        \"studyId\": \"syn64954831\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"ATAC-seq\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 1,\n        \"specimenCount\": 1\n    },\n    {\n        \"title\": \"Cxcl18b injury dep gene exp\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"quantitative PCR\", \"Danio rerio\", \"geneExpression\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954832\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"quantitative PCR\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"Cxcl18b knockdown EdU\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"Danio rerio\", \"immunoassay\"],\n        \"dataType\": [\"immunoassay\"],\n        \"studyId\": \"syn64954833\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"Drug screen\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"Danio rerio\", \"drugScreen\"],\n        \"dataType\": [\"drugScreen\"],\n        \"studyId\": \"syn64954834\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 1\n    },\n    {\n        \"title\": \"Flt1 knockdown and mutant EdU injury data\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"immunofluorescence\", \"Danio rerio\", \"immunoassay\"],\n        \"dataType\": [\"immunoassay\"],\n        \"studyId\": \"syn64954835\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"immunofluorescence\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"Images NF1 knockdown\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"immunofluorescence\", \"image\"],\n        \"dataType\": [\"image\"],\n        \"studyId\": \"syn64954836\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"immunofluorescence\"]\n    },\n    {\n        \"title\": \"Myc\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"quantitative PCR\", \"immunofluorescence\", \"geneExpression\", \"cellularPhysiology\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\", \"cellularPhysiology\"],\n        \"studyId\": \"syn64954837\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"quantitative PCR\", \"immunofluorescence\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"NF1 qPCR and MO knockdown\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"quantitative PCR\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954838\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"quantitative PCR\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 1,\n        \"specimenCount\": 1\n    },\n    {\n        \"title\": \"RNAseq Ascl1a-Lin28a v control\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954840\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"RNA-seq\"],\n        \"species\": [\"Danio rerio\"],\n        \"individualCount\": 1,\n        \"specimenCount\": 1\n    },\n    {\n        \"title\": \"RNAseq DAPT v DMSO MG\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954841\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"RNA-seq\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"RNAseq inj v uninj MG\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954842\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"RNA-seq\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"RNAseq uninj v inj retina non-Muller glia\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"RNA-seq\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954843\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"RNA-seq\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"Vegf signaling component gene expression\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"quantitative PCR\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954845\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"quantitative PCR\"],\n        \"species\": [\"Danio rerio\"]\n    },\n    {\n        \"title\": \"scRNAseq zf retina\",\n        \"creator\": [\"Daniel Goldman, PhD\"],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\"single-cell RNA-seq\", \"geneExpression\", \"Danio rerio\"],\n        \"dataType\": [\"geneExpression\"],\n        \"studyId\": \"syn64954846\",\n        \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n        \"funder\": [\"GFF\"],\n        \"measurementTechnique\": [\"single-cell RNA-seq\"],\n        \"species\": [\"Danio rerio\"]\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7198, "completion_tokens": 2481, "total_tokens": 9679, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba98a9c8190bef4dc205fba8eaf", "custom_id": "syn27761862", "response": {"status_code": 200, "request_id": "e0bd8cbabff97957314183554badbfc4", "body": {"id": "chatcmpl-BHNVpLuG6jman3jOeEvo5b7YhQ8jY", "object": "chat.completion", "created": 1743481657, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Proteasome-targeting drugs tested on NF2-deficient meningioma models\",\n    \"creator\": [\n      \"Roberta Beauchamp\",\n      \"Anh Nguyet Vu\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2\",\n      \"meningioma\",\n      \"proteasome\",\n      \"drug screening\",\n      \"kinome\",\n      \"transcriptome\",\n      \"cell viability\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn27761862\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Dataset includes results from testing proteasome-targeting drugs on NF2-deficient meningioma models, involving cell viability assays conducted on human and mouse cell lines.\",\n    \"contributor\": [\n      \"Vijaya Ramesh\",\n      \"Lei Xu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4899, "completion_tokens": 311, "total_tokens": 5210, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9a34481909de6a512997c1a8a", "custom_id": "syn11374341", "response": {"status_code": 200, "request_id": "0f40c871007571df9a98a535213b27c1", "body": {"id": "chatcmpl-BHNVqwuBrdeGSkQHI6ZxxtVGkXil1", "object": "chat.completion", "created": 1743481658, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Kallionpaa et al., Dermatology 2022\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\",\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Cutaneous Neurofibroma\",\n      \"T-cells\",\n      \"Mast cells\",\n      \"Brightfield Microscopy\",\n      \"Tumor Biology\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Kallionpaa Dermatology 2022 Dataset\",\n    \"contributor\": [\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"countryOfOrigin\": [\n      \"Homo sapiens\"\n    ],\n    \"datePublished\": 2022,\n    \"description\": \"This dataset explores the microenvironmental targets of cutaneous neurofibromas, particularly focusing on T-cells and mast cells as contributors to tumor growth.\",\n    \"individualCount\": 61,\n    \"specimenCount\": 183,\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Kallionpaa et al., Immune cell populations in cNFs, T cell receptor sequencing\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\",\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Cutaneous Neurofibroma\",\n      \"T-cells\",\n      \"T cell receptor sequencing\",\n      \"Tumor Microenvironment\"\n    ],\n    \"dataType\": [],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Kallionpaa Immune Cell Populations Dataset\",\n    \"contributor\": [\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Kallionpaa et al., Mass spectrometry of human cutaneous neurofibromas and the overlying skin\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\",\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Cutaneous Neurofibroma\",\n      \"Mast cells\",\n      \"Mass spectrometry\",\n      \"Proteomics\",\n      \"Tumor Microenvironment\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Kallionpaa Mass Spectrometry Dataset\",\n    \"contributor\": [\n      \"Roope Kallionp\u00e4\u00e4\"\n    ],\n    \"measurementTechnique\": [\n      \"LC-MSMS\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5015, "completion_tokens": 852, "total_tokens": 5867, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9c9908190874d53bbfffcfab6", "custom_id": "syn11374337", "response": {"status_code": 200, "request_id": "cfa5e70ccf7a5fc01ab59532fa8b8239", "body": {"id": "chatcmpl-BHNVve7uaO9Evu3BuzxgDLI2o1FJM", "object": "chat.completion", "created": 1743481663, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n    {\n        \"title\": \"Chronic injuries experiment\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"Chronic injuries\",\n            \"cutaneus neurofibroma\",\n            \"immunofluorescence\",\n            \"Mus musculus\",\n            \"image data\"\n        ],\n        \"dataType\": [\n            \"image\"\n        ],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"individualCount\": 27,\n        \"measurementTechnique\": [\n            \"immunofluorescence\"\n        ],\n        \"species\": [\n            \"Mus musculus\"\n        ],\n        \"manifestation\": [\n            \"Cutaneous Neurofibroma\"\n        ],\n        \"description\": \"This dataset contains image data from experiments on chronic injuries using a mouse model. Assays include immunofluorescence, focusing on cutaneous neurofibroma.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Development of cNFs\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"cNFs\",\n            \"development\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"description\": \"This dataset focuses on the development of cutaneous neurofibromas (cNFs) in mouse models for studying origin and progression of Neurofibromatosis type 1.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Grafts of tumor cells into sciatic nerve\",\n        \"creator\": [\n            \"Piotr Topilko\",\n            \"Christina Parry\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"tumor graft\",\n            \"sciatic nerve\",\n            \"in vivo tumor growth\",\n            \"image data\"\n        ],\n        \"dataType\": [\n            \"image\"\n        ],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"individualCount\": 11,\n        \"measurementTechnique\": [\n            \"in vivo tumor growth\"\n        ],\n        \"species\": [\n            \"Mus musculus\"\n        ],\n        \"manifestation\": [\n            \"Cutaneous Neurofibroma\"\n        ],\n        \"description\": \"A dataset of images capturing grafts of tumor cells into the sciatic nerve of a mouse model to study Neurofibromatosis type 1.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Mouse model cutaneous imaging of chronic injuries\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"cutaneous imaging\",\n            \"chronic injuries\",\n            \"Mus musculus\"\n        ],\n        \"dataType\": [],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"individualCount\": 27,\n        \"description\": \"This dataset includes imaging data related to chronic injuries in a mouse model of cutaneous neurofibromas.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"NFOSI-RNASeq-To-Process-2023-15-03\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RNASeq\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"description\": \"RNA sequencing data, yet to be processed, for studying Neurofibromatosis type 1. Parts of the NFOSI project.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"RNAseq Bulk Sphere P0 vs P5\",\n        \"creator\": [\n            \"Piotr Topilko\",\n            \"Kaitlin Throgmorton\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"RNAseq\",\n            \"gene expression\",\n            \"Mus musculus\",\n            \"Neurofibromatosis type 1\"\n        ],\n        \"dataType\": [\n            \"geneExpression\"\n        ],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"measurementTechnique\": [\n            \"RNA-seq\"\n        ],\n        \"species\": [\n            \"Mus musculus\"\n        ],\n        \"description\": \"Bulk RNA sequencing data comparing sphere cultures P0 vs P5 from a mouse model. Assays include RNA-seq to study changes in gene expression related to Neurofibromatosis type 1.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Single cell transcriptomic analysis, for the identification of new markers of supepidermal glia\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"single cell analysis\",\n            \"transcriptomics\",\n            \"supepidermal glia\"\n        ],\n        \"dataType\": [],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"description\": \"This dataset contains transcriptomic data for single cell analysis aimed at identifying new markers for supepidermal glia.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    },\n    {\n        \"title\": \"Vascular detection with Itae\",\n        \"creator\": [\n            \"Piotr Topilko\"\n        ],\n        \"accessType\": \"Controlled Access\",\n        \"license\": \"UNKNOWN\",\n        \"keywords\": [\n            \"vascular detection\",\n            \"Itae\"\n        ],\n        \"dataType\": [],\n        \"studyId\": \"syn11374337\",\n        \"diseaseFocus\": [\n            \"Neurofibromatosis type 1\"\n        ],\n        \"funder\": [\n            \"NTAP\"\n        ],\n        \"description\": \"A dataset involving vascular detection using the Itae method, related to Neurofibromatosis type 1 research.\",\n        \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n    }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5952, "completion_tokens": 1654, "total_tokens": 7606, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9dd288190adfb200a8c48cff9", "custom_id": "syn11638893", "response": {"status_code": 200, "request_id": "c1319914fef43701952ac8556b5bf925", "body": {"id": "chatcmpl-BHNW5xnO0UFC6e3JpbRmNGFiwIYdT", "object": "chat.completion", "created": 1743481673, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Copy Number Variation - CNVkit\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Copy Number Variation\", \"CNVkit\", \"Neurofibromatosis type 1\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"dataType\": [\"CopyNumberVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"UNKNOWN\"],\n    \"description\": \"Dataset containing Copy Number Variation data generated using CNVkit for NF1-related MPNSTs.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"Filtered Single Cell RNASeq Data\",\n    \"creator\": [\"UNKNOWN\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Single Cell RNASeq\", \"Gene Expression\", \"Neurofibromatosis type 1\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"dataType\": [\"geneExpression\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Filtered single-cell RNA sequencing data for NF1-related MPNSTs.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 8,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"measurementTechnique\": [\"single-cell RNA-seq\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"Germline Genomic Variants - DeepVariant Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"DeepVariant\", \"Neurofibromatosis type 1\", \"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Germline genomic variant data generated using the DeepVariant pipeline for NF1-related MPNSTs.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"Germline Genomic Variants - FreeBayes Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"FreeBayes\", \"Neurofibromatosis type 1\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Germline genomic variant data generated using the FreeBayes pipeline for NF1-related conditions.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Mutect2 Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"Mutect2\", \"Neurofibromatosis type 1\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Germline genomic variant data generated using the Mutect2 pipeline for NF1-related conditions.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"Germline Genomic Variants - Strelka Pipeline\",\n    \"creator\": [\"NF Service\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Germline Genomic Variants\", \"Strelka\", \"Neurofibromatosis type 1\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Germline genomic variant data generated using the Strelka pipeline for NF1-related conditions.\",\n    \"species\": [\"Homo sapiens\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"NFOSI-WES-To-Process-2024-09\",\n    \"creator\": [\"Chang In Moon\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Exome Sequencing\", \"Neurofibromatosis type 1\", \"MPNST\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Whole exome sequencing dataset related to NFOSI processing for NF1 and MPNST studies.\",\n    \"species\": [\"Mus musculus (humanized)\", \"Homo sapiens\"],\n    \"individualCount\": 6,\n    \"specimenCount\": 13,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"measurementTechnique\": [\"whole exome sequencing\"],\n    \"datePublished\": 2023\n  },\n  {\n    \"title\": \"NFOSIprocessing-2022-26-04\",\n    \"creator\": [\"Chang In Moon\"],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\"Whole Genome Sequencing\", \"Neurofibromatosis type 1\", \"MPNST\"],\n    \"dataType\": [\"genomicVariants\"],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\"Neurofibromatosis type 1\"],\n    \"funder\": [\"NTAP\", \"NFRI\"],\n    \"description\": \"Whole genome sequencing dataset from NFOSI processing for NF1 and MPNST studies.\",\n    \"species\": [\"Homo sapiens\", \"Mus musculus (humanized)\"],\n    \"individualCount\": 5,\n    \"specimenCount\": 11,\n    \"dataUseModifiers\": [\"General Research Use\"],\n    \"manifestation\": [\"Malignant Peripheral Nerve Sheath Tumor\"],\n    \"measurementTechnique\": [\"whole genome sequencing\"],\n    \"datePublished\": 2023\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 7122, "completion_tokens": 1763, "total_tokens": 8885, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6ba9f1148190ac6319f4428ba24a", "custom_id": "syn23662493", "response": {"status_code": 200, "request_id": "27ac611e869acc694bd848dbdeb2f0ad", "body": {"id": "chatcmpl-BHNWE0BT7HxSfgwpG3phIK1cR5HZj", "object": "chat.completion", "created": 1743481682, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Affinity Purified ELISA Screen\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"ELISA\",\n      \"immunoassay\",\n      \"neurofibromin\",\n      \"antibody development\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"ELISA\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"This dataset contains ELISA assay data for affinity purified screening geared towards enhancing the development of monoclonal antibodies against neurofibromin.\"\n  },\n  {\n    \"title\": \"Epitope Mapping\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Western blot\",\n      \"immunoassay\",\n      \"epitope mapping\",\n      \"neurofibromin\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"This dataset includes data from western blot assays used for epitope mapping aimed at identifying regions of neurofibromin for antibody development.\"\n  },\n  {\n    \"title\": \"IHC Data\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"IHC\",\n      \"immunohistochemistry\",\n      \"neurofibromin\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Dataset containing immunohistochemistry (IHC) images for evaluating the application of developed antibodies in tissue samples.\"\n  },\n  {\n    \"title\": \"Sandwich ELISA\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Sandwich ELISA\",\n      \"immunoassay\",\n      \"neurofibromin\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"This dataset provides data from sandwich ELISA assays used to validate the specificity and sensitivity of new monoclonal antibodies.\"\n  },\n  {\n    \"title\": \"Sequence Data\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"geneExpression\",\n      \"neurofibromin\"\n    ],\n    \"dataType\": [\n      \"proteomics\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"liquid chromatography/tandem mass spectrometry\",\n      \"next generation targeted sequencing\"\n    ],\n    \"species\": [\n      \"Oryctolagus cuniculus\"\n    ],\n    \"description\": \"Sequence data from liquid chromatography and next-generation sequencing techniques to analyze protein expressions related to neurofibromin.\"\n  },\n  {\n    \"title\": \"Western Blot Screening\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Western blot\",\n      \"immunoassay\",\n      \"neurofibromin\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"description\": \"Western blot screening dataset used to identify monoclonal antibodies with increased sensitivity and specificity against neurofibromin.\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 5557, "completion_tokens": 1161, "total_tokens": 6718, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
{"id": "batch_req_67eb6baa02b881908a6fdb22e9e46e3c", "custom_id": "syn4939888", "response": {"status_code": 200, "request_id": "ba9d4adee870633975875ee9d2d1424e", "body": {"id": "chatcmpl-BHNWLzweRzbZN6r7IBi9MfBTBl6Y2", "object": "chat.completion", "created": 1743481689, "model": "gpt-4o-2024-08-06", "choices": [{"index": 0, "message": {"role": "assistant", "content": "```json\n[\n  {\n    \"title\": \"Patient Reported Outcomes Dataset\",\n    \"creator\": [\n      \"Jin-Shei Lai\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"PRO\",\n      \"patient reported outcomes\",\n      \"NF1\",\n      \"health-related quality of life\",\n      \"psychometric analysis\"\n    ],\n    \"dataType\": [\n      \"surveyData\"\n    ],\n    \"studyId\": \"syn4939888\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"questionnaire\"\n    ],\n    \"description\": \"This dataset contains patient-reported outcomes related to health-related quality of life for patients with NF1-associated plexiform neurofibromas. The data were collected through questionnaires as part of a study to develop reliable PRO measures for use in clinical trials.\",\n    \"contributor\": [\n      \"Jin-Shei Lai\",\n      \"Sara Gosline\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 4913, "completion_tokens": 261, "total_tokens": 5174, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_898ac29719"}}, "error": null}
